id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1100,17307975,2007,alK-lK-lK-lK,{nnr:alK}-{nnm:l}K-{nnm:l}K-{nnm:l}K,OAK 1,Free,Free,Linear,Mix,"a = amino, l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,24.6± 1.2% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1101,17307975,2007,lK-lK-lK-lK,{nnm:l}K-{nnm:l}K-{nnm:l}K-{nnm:l}K,OAK 2,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,26.1±4.5% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1102,17307975,2007,K-lK-lK-lK,K-{nnm:l}K-{nnm:l}K-{nnm:l}K,OAK 3,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,2.3±1.5% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1103,17307975,2007,alK-lK-lK,{nnr:alK}-{nnm:l}K-{nnm:l}K,OAK 4,Free,Free,Linear,Mix,"a = amino, l = lauric acid",3,Antiplasmodial,3.4±0.8% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1104,17307975,2007,lK-lK-lK,{nnm:l}K-{nnm:l}K-{nnm:l}K,OAK 5,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",3,Antiplasmodial,13.3±4.3% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1105,17307975,2007,K-lK-lK,K-{nnm:l}K-{nnm:l}K,OAK 6,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",3,Antiplasmodial,<0.1% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1106,17307975,2007,alK-lK,{nnr:alK}-{nnm:l}K,OAK 7,Free,Free,Linear,Mix,"a = amino, l = lauric acid, alK = aminolauryl-lysine",2,Antiplasmodial,0.14±0.3% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1107,17307975,2007,lK-lK,{nnm:l}K-{nnm:l}K,OAK 8,Free,Free,Linear,Mix,l = lauric acid,2,Antiplasmodial,4.9±1.7% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1108,17307975,2007,K-lK,K-{nnm:l}K,OAK 9,Free,Free,Linear,Mix,l = lauric acid,2,Antiplasmodial,<0.1% Hemolysis at 100 µM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA,NA,NA
1118,17328560,2007,FFHHIFRaIVHVaKTIHRLVTG,FFHHIFRA{d}IVHVA{d}KTIHRLVTG,Pis-1 aa,Free,Free,Linear,Mix,None,22,Cytotoxic,HC50 = 8 µM,Human,Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ),α-helix,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
1283,19132829,2009,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,HC50 = 21.1(±2.6)µM,Sheep,Gramicidin S (Bacillus brevis),β-sheet structure,NA,NA,NA
1284,19132829,2009,VOL-hpa-PVOL-hpa-P,V{nnr:O}L{nnr:hpa}PV{nnr:O}L{nnr:hpa}P{cyc:NC},GS1,Free,Free,Cyclic,Mix,"O = L-Ornithine, Hpa = homophenylalanine",10,Antimicrobial,HC50 = 7.0(±0.3)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1285,19132829,2009,VOL-1-nal-PVOL-1-nal-P,V{nnr:O}L{nnr:1nal}PV{nnr:O}L{nnr:1nal}P{cyc:NC},GS2,Free,Free,Cyclic,Mix,"O = L-Ornithine, 1-Nal = 1-naphthylalanine",10,Antimicrobial,HC50 = 5.0(±0.1)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1286,19132829,2009,VOL-2-nal-PVOL-2-nal-P,V{nnr:O}L{nnr:2nal}PV{nnr:O}L{nnr:2nal}P{cyc:NC},GS3,Free,Free,Cyclic,Mix,"O = L-Ornithine, 2-Nal = 2-naphthylalanine",10,Antimicrobial,HC50 = 7.1(±3.5)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1287,19132829,2009,VOL-dip-PVOL-dip-P,V{nnr:O}L{nnr:dip}PV{nnr:O}L{nnr:dip}P{cyc:NC},GS4,Free,Free,Cyclic,Mix,"O = L-Ornithine, Dip = β,β-diphenylalanine",10,Antimicrobial,HC50 = 8.6(±1.1)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1288,19132829,2009,VOL-flg-PVOL-flg-P,V{nnr:O}L{nnr:flg}PV{nnr:O}L{nnr:flg}P{cyc:NC},GS5,Free,Free,Cyclic,Mix,"O = L-Ornithine, Flg = fluorenylglycine",10,Antimicrobial,HC50 = 6.2(±0.3)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1289,19132829,2009,VOL-tic-PVOL-tic-P,V{nnr:O}L{nnr:tic}PV{nnr:O}L{nnr:tic}P{cyc:NC},GS6,Free,Free,Cyclic,Mix,"O = L-Ornithine, Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid",10,Antimicrobial,HC50 >50 µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1356,19445503,2009,RRGWVLALVlRYGRR,RRGWVLALVL{d}RYGRR,dVAVR,Free,Free,Linear,Mix,None,15,Antimicrobial,5±6 % Hemolysis at 15 µM,Human,Synthetic peptide,β-sheet,NA,CCSCSTTHHHHTCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
1357,19445503,2009,RRGWVLALVlRYGRR,RRGWVLALVL{d}RYGRR,dVAVR,Free,Free,Linear,Mix,None,15,Antimicrobial,0 % Hemolysis at 15 µM,Sheep,Synthetic peptide,β-sheet,NA,CCSCSTTHHHHTCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
1358,19445503,2009,RRGWVLALYlRYGRR,RRGWVLALYL{d}RYGRR,dVAYR,Free,Free,Linear,Mix,None,15,Antimicrobial,5±3% Hemolysis at 15 µM,Human,Synthetic peptide,β-sheet,NA,CCCCCCCCCTTTCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1359,19445503,2009,RRGWVLALYlRYGRR,RRGWVLALYL{d}RYGRR,dVAYR,Free,Free,Linear,Mix,None,15,Antimicrobial,15±20% Hemolysis at 15 µM,Sheep,Synthetic peptide,β-sheet,NA,CCCCCCCCCTTTCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1360,19445503,2009,RRGWALRLVlAY,RRGWALRLVL{d}AY,dARVA,Free,Free,Linear,Mix,None,12,Antimicrobial,4% Hemolysis at 15 µM,Human,Synthetic peptide,β-sheet,NA,CCSCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
1361,19445503,2009,RRGWALRLVlAY,RRGWALRLVL{d}AY,dARVA,Free,Free,Linear,Mix,None,12,Antimicrobial,10±12 % Hemolysis at 15 µM,Sheep,Synthetic peptide,β-sheet,NA,CCSCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
1362,19445503,2009,WVLVLRlGY,WVLVLRL{d}GY,dVVRG,Free,Free,Linear,Mix,None,9,Antimicrobial,12±13 % Hemolysis at 15 µM,Human,Synthetic peptide,β-sheet,NA,CCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
1363,19445503,2009,WVLVLRlGY,WVLVLRL{d}GY,dVVRG,Free,Free,Linear,Mix,None,9,Antimicrobial,11±9% Hemolysis at 15 µM,Sheep,Synthetic peptide,β-sheet,NA,CCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
1462,19635451,2010,GIGAvLKvLAlISWIkRKR,GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid},Mel-dH,Amidation,Free,Linear,Mix,None,19,Antimicrobial,5% Hemolysis at 0.4 µM,Human,Melittin analog (venom of European honey bee),α-helix,NA,CHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
1463,19635451,2010,GIGAvLKvLAlISWIkRKR,GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid},Mel-dH,Amidation,Free,Linear,Mix,None,19,Antimicrobial,12 % Hemolysis at 23 µM,Human,Melittin analog (venom of European honey bee),α-helix,NA,CHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
1502,20449481,2010,VOLLfPVOLfP,V{nnr:O}LLF{d}PV{nnr:O}LF{d}P{cyc:N-C},2HBr (1),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,100% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1503,20449481,2010,VOLAfPVOLfP,V{nnr:O}LAF{d}PV{nnr:O}LF{d}P{cyc:N-C},2HBr (2),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,50% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1504,20449481,2010,VOLOfPVOLfP,V{nnr:O}L{nnr:O}F{d}PV{nnr:O}LF{d}P{cyc:N-C},3HBr (3),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,10% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1505,20449481,2010,VOLKfPVOLfP,V{nnr:O}LKF{d}PV{nnr:O}LF{d}P{cyc:N-C},3HBr (4),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,10% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1506,20449481,2010,VOLRfPVOLfP,V{nnr:O}LRF{d}PV{nnr:O}LF{d}P{cyc:N-C},3HCl (5),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,15% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1529,20665599,2010,KlKkLlKkWlKlLkKlLk,KL{d}KK{d}LL{d}KK{d}WL{d}KL{d}LK{d}KL{d}LK{d}{ct:Amid},D9-K9L8W,Amidation,Free,Linear,Mix,None,18,Antifungal,HC50 <800 µM,Human,Synthetic peptide,α-helix,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1564,14709550,2004,kGGGkWGGkGGk,K{d}GGGK{d}WGGK{d}GGK{d}{nt:Palmitoylation}{ct:Amid},PA-D-G,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,>75% Hemolysis at 100 µM,Human,Synthetic peptide,Random coils,NA,NA,NCCCC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)O
1565,14709550,2004,KAaaKWAaKaAK,KAA{d}A{d}KWAA{d}KA{d}AK{nt:Palmitoylation}{ct:Amid},PA-D-A,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,<25% Hemolysis at 100 µM,Human,Synthetic peptide,Random coils,NA,NA,C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
1566,14709550,2004,KVvvKWVvKvVK,KVV{d}V{d}KWVV{d}KV{d}VK{nt:Palmitoylation}{ct:Amid},PA-D-V,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,100% Hemolysis at 100 µM,Human,Synthetic peptide,β-aggregates,NA,NA,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
1567,14709550,2004,KLllKWLlKlLK,KLL{d}L{d}KWLL{d}KL{d}LK{nt:Palmitoylation}{ct:Amid},PA-D-L,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,>75% Hemolysis at 100 µM,Human,Synthetic peptide,α-helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1572,14733952,2004,KWKKLLKKpLKLLKKLLK,KWKKLLKKP{d}LKLLKKLLK{ct:Amid},KLW-L9p,Amidation,Free,Linear,Mix,None,18,Antimicrobial,<5 % Hemolysis at 50 µM,Human,Synthetic peptide,α-helical,NA,CCTTSTTTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1573,14733952,2004,KWKKLLKKpLKLLKKLLK,KWKKLLKKP{d}LKLLKKLLK{ct:Amid},KLW-L9p,Amidation,Free,Linear,Mix,None,18,Antimicrobial,~5% Hemolysis at 100 µM,Human,Synthetic peptide,α-helical,NA,CCTTSTTTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1576,14733952,2004,KWKKLLKKLLpLLKKLLK,KWKKLLKKLLP{d}LLKKLLK{ct:Amid},KLW-K11p,Amidation,Free,Linear,Mix,None,18,Antimicrobial,<20% Hemolysis at 50 µM,Human,Synthetic peptide,α-helical,NA,CHHHHHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1577,14733952,2004,KWKKLLKKLLpLLKKLLK,KWKKLLKKLLP{d}LLKKLLK{ct:Amid},KLW-K11p,Amidation,Free,Linear,Mix,None,18,Antimicrobial,>30% Hemolysis at 100 µM,Human,Synthetic peptide,α-helical,NA,CHHHHHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1584,15009528,2004,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14KD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 125 μg/ml,Human,Gramicidin S analog,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1585,15009528,2004,VKLlVyPLKVKLyP,VKLL{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14LD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 5 μg/ml,Human,Gramicidin S analog,NA,NA,CCCEEETTEEECCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1586,15009528,2004,VKLfVyPLKVKLyP,VKLF{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14FD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1587,15009528,2004,VKLyVyPLKVKLyP,VKLY{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14YD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 5 μg/ml,Human,Gramicidin S analog,NA,NA,CCCSSSSSSCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1588,15009528,2004,VKLnVyPLKVKLyP,VKLN{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14ND4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 62 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSCTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1687,16730857,2006,KLKfKLKQ,KLKF{d}KLKQ{cyc:N-C},BPC8D,Free,Free,Cyclic,Mix,None,8,Hemolytic,37±5.2% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1688,16730857,2006,KLKLKfKLKQ,KLKLKF{d}KLKQ{cyc:N-C},BPC10D,Free,Free,Cyclic,Mix,None,10,Hemolytic,42± 6.8% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCTTSCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1734,17176094,2006,RGGRLTYTRpRFTVTVGR,RGGRLTYTRP{d}RFTVTVGR{ct:Amid},TTpTT,Amidation,Free,Linear,Mix,None,18,Antimicrobial,~10% Hemolysis at above 100 μg/ml,Human,Protegrins analog (porcine),NA,NA,CCSBSSCSSSSCCCCBCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
1735,17176094,2006,RGGRLVYTRp*RFTVIVGR,RGGRLVYTR{nnr:p*}RFTVIVGR{ct:Amid},TTp*TT,Amidation,Free,Linear,Mix,p* = amino-functionalized D-proline,18,Antimicrobial,~20% Hemolysis at above 100 μg/ml,Human,Protegrins analog (porcine),NA,NA,NA,NA
1736,17176094,2006,RGGRLCYTRpRFTVCVGR,RGGRLCYTRP{d}RFTVCVGR{ct:Amid},CTpTC,Amidation,Free,Linear,Mix,None,18,Antimicrobial,~60% Hemolysis at above 100 μg/ml,Human,Protegrins analog (porcine),NA,NA,CTTSSSCSSSSCSSGGGC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
1804,17560323,2007,HFLkTLVNLAKKIL,HFLK{d}TLVNLAKKIL{ct:Amid},D-Lys-4,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 110 µM,Human,Analogs of temporin-1DRa,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
1805,17560323,2007,HFLLkLVNLAKKIL,HFLLK{d}LVNLAKKIL{ct:Amid},D-Lys-5,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 500 µM,Human,Analogs of temporin-1DRa,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
1806,17560323,2007,HFLLTLkNLAKKIL,HFLLTLK{d}NLAKKIL{ct:Amid},D-Lys-7,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 500 µM,Human,Analogs of temporin-1DRa,NA,NA,CCSSHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
1807,17560323,2007,HFLLTLVKLAKKIL,HFLLTLVKLAKKIL{ct:Amid},D-Lys-8,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 385 µM,Human,Analogs of temporin-1DRa,NA,NA,CCSTHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
1808,17560323,2007,HFLLTLVNLAkKIL,HFLLTLVNLAK{d}KIL{ct:Amid},D-Lys-11,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 210 µM,Human,Analogs of temporin-1DRa,NA,NA,CCSSHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
1809,17560323,2007,HFLLTLVNLAKkIL,HFLLTLVNLAKK{d}IL{ct:Amid},D-Lys-12,Amidation,Free,Linear,Mix,None,14,Antimicrobial,LD50 = 500 µM,Human,Analogs of temporin-1DRa,NA,NA,CCSSHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
1907,16730857,2006,KfKQ,KF{d}KQ{cyc:N-C},BPC4D,Free,Free,Cyclic,Mix,None,4,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1908,16730857,2006,KfKLKQ,KF{d}KLKQ{cyc:N-C},BPC6D,Free,Free,Cyclic,Mix,None,6,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1951,18554256,2008,GFKkLLKGAAKALVKTVLF,GFKK{d}LLKGAAKALVKTVLF{ct:Amid},D-Lys-4,Amidation,Free,Linear,Mix,None,19,Antimicrobial,LD50 = 300 µM,Human,Ascaphin-8 analog (Ascaphus truei),NA,NA,CHHHHHHHHHHHHTTTSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1952,18554256,2008,GFKDLLKkAAKALVKTVLF,GFKDLLKK{d}AAKALVKTVLF{ct:Amid},D-Lys-8,Amidation,Free,Linear,Mix,None,19,Antimicrobial,LD50 = 150 µM,Human,Ascaphin-8 analog (Ascaphus truei),NA,NA,CHHHHHHHHHHHHTTTSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1953,18554256,2008,GFKDLLKGAkKALVKTVLF,GFKDLLKGAK{d}KALVKTVLF{ct:Amid},D-Lys-10,Amidation,Free,Linear,Mix,None,19,Antimicrobial,LD50 >500 µM,Human,Ascaphin-8 analog (Ascaphus truei),NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1954,18554256,2008,GFKDLLKGAAKALVKTVLF,GFKDLLKGAAKALVKTVLF{ct:Amid},D-Lys-14,Amidation,Free,Linear,Mix,None,19,Antimicrobial,LD50 >500 µM,Human,Ascaphin-8 analog (Ascaphus truei),NA,NA,CHHHHIIIIIHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1955,18554256,2008,GFKDLLKGAAKALVKTVkF,GFKDLLKGAAKALVKTVK{d}F{ct:Amid},D-Lys-18,Amidation,Free,Linear,Mix,None,19,Antimicrobial,LD50 >500 µM,Human,Ascaphin-8 analog (Ascaphus truei),NA,NA,CHHHHHHHHHHHHHHSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1977,11478963,2001,LkLKSIVSWAKKVL,LK{d}LKSIVSWAKKVL{ct:Amid},[D-Lys2]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,84-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1978,11478963,2001,LkLKSIVSWAKKVL,LK{d}LKSIVSWAKKVL{ct:Amid},[D-Lys2]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,85-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1979,11478963,2001,LKLkSIVSWAKKVL,LKLK{d}SIVSWAKKVL{ct:Amid},[D-Lys4]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,86-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1980,11478963,2001,LKLkSIVSWAKKVL,LKLK{d}SIVSWAKKVL{ct:Amid},[D-Lys4]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,87-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1981,11478963,2001,LKLKSIVSWAkkVL,LKLKSIVSWAK{d}K{d}VL{ct:Amid},"[D-Lys11,12]-MP-B",Amidation,Free,Linear,Mix,None,14,Hypotensive,88-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1982,11478963,2001,LKLKSIVSWAkkVL,LKLKSIVSWAK{d}K{d}VL{ct:Amid},"[D-Lys11,12]-MP-B",Amidation,Free,Linear,Mix,None,14,Hypotensive,89-85% Hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA,CCCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
2098,11168889,2000,PKLlKTFlSKWIG,PKLL{d}KTFL{d}SKWIG,Diastereo SPFK (DSac),Free,Free,Linear,Mix,None,13,Antimicrobial,~10% hemolsis at 60 μg/ml,Rat,Synthetic peptide,NA,NA,CCGGGTTSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
2099,11168889,2000,PKLlETFlSKWIG,PKLL{d}ETFL{d}SKWIG{ct:Amid},Diastereo SPFK amide (DSam),Amidation,Free,Linear,Mix,None,13,Antimicrobial,~40 % Hemolysis at 60 μg/ml,Rat,Synthetic peptide,NA,NA,CCHHIIIIITTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
2201,12110678,2002,LKlLKkLlkKLLkLL,LKL{d}LKK{d}LL{d}K{d}KLLK{d}LL{ct:Amid},Amphipathic-1D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2202,12110678,2002,LLkKLlKllLKLlKK,LLK{d}KLL{d}KL{d}L{d}LKLL{d}KK{ct:Amid},Amphipathic-2D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CHHHHHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2203,12110678,2002,LLkLLkKllKKLlKL,LLK{d}LLK{d}KL{d}L{d}KKLL{d}KL{ct:Amid},Amphipathic-3D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTTHHHHHTTCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2204,12110678,2002,KLkLLkLlkLLKlLK,KLK{d}LLK{d}LL{d}K{d}LLKL{d}LK{ct:Amid},Scrambled-4D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCTHHHHHHTGGGC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2205,12110678,2002,KKkLLlLllLLLkKK,KKK{d}LLL{d}LL{d}L{d}LLLK{d}KK{ct:Amid},Scrambled-5D,Amidation,Free,Linear,Mix,None,15,Antibacterial,3% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCTHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2206,12110678,2002,LLlLLkKkkKKLlLL,LLL{d}LLK{d}KK{d}K{d}KKLL{d}LL{ct:Amid},Scrambled-6D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCSSCGGGTCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2286,12712499,2003,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,NA,NA
2287,12712499,2003,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2288,12712499,2003,KyPKyP,KY{d}PKY{d}P{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2289,12712499,2003,VKyPKLyP,VKY{d}PKLY{d}P{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2290,12712499,2003,VKLyPVKLyP,VKLY{d}PVKLY{d}P{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2291,12712499,2003,VKLKyPKVKLyP,VKLKY{d}PKVKLY{d}P{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCTTCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2292,12712499,2003,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2293,12712499,2003,vKLKVyPLKVKLyP,V{d}KLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2294,12712499,2003,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2295,12712499,2003,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2296,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2297,12712499,2003,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2298,12712499,2003,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2299,12712499,2003,VKLKVyplKVKLyP,VKLKVY{d}P{d}L{d}KVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2300,12712499,2003,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2301,12712499,2003,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2302,12712499,2003,VKLKVyPLKvKLyP,VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2303,12712499,2003,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2304,12712499,2003,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2305,12712499,2003,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2306,12712499,2003,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2307,12712499,2003,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14 K3L4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2308,12712499,2003,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"GS14K4 Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2309,12712499,2003,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},GS14K4 V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2310,12712499,2003,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},GS14K4 Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2311,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2312,12712499,2003,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},GS14K4 V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2313,12712499,2003,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},GS14K4 L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2314,12712499,2003,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},GS14K4 V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCTTCCCCC,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2420,11606214,2001,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,Strong Hemolysis,Human,Gramicidin S,NA,NA,NA,NA
2421,11606214,2001,VKLyPVKLyP,VKLY{d}PVKLY{d}P{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antimicrobial,Strong Hemolysis,Human,Gramicidin S analogs,NA,NA,CCSSCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2422,11606214,2001,VKLKyPKVKLyP,VKLKY{d}PKVKLY{d}P{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antimicrobial,Weak Hemolysis,Human,Gramicidin S analogs,NA,NA,CCTTCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2423,11606214,2001,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,Very strong Hemolysis,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2424,11606214,2001,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},[D-Lys]4GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,Weak Hemolysis,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2425,11682479,2002,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 1.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2426,11682479,2002,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 12.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2427,11682479,2002,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 25 μg/ml,Human,Synthetic peptide,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2428,11682479,2002,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 40 μg/ml,Human,Synthetic peptide,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2429,11682479,2002,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 200 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2430,11682479,2002,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2431,11682479,2002,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2432,11682479,2002,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,NA,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2453,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCSCTTSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2454,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCSCTTSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2455,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,1% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSSCTTTCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2456,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,8% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSSCTTTCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2457,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,3% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSSSSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2458,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,37% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSSSSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2472,12168695,2002,GIGAVLKVLTTGLpALISWIKRKRQQ,GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{ct:Amid},Melittin-1,Amidation,Free,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2473,12168695,2002,GIGAVLKVLTTGLpALISWIKFKRQQ,GIGAVLKVLTTGLP{d}ALISWIKFKRQQ{ct:Amid},Melittin-2,Amidation,Free,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >80 μg/ml,Human,Melittin analogs,NA,NA,CCCCCSSCTTCCCHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2474,12168695,2002,GIGAVLKVLTTGLpALISWIKXXKRQQ,GIGAVLKVLTTGLP{d}ALISWIKXXKRQQ{ct:Amid},Melittin-1P,Amidation,Free,Linear,Mix,None,27,Antibacterial,50% Hemolysis at >18 μg/ml,Human,Melittin analogs,NA,NA,NA,NA
2475,12168695,2002,GIGAVLKVLTTGLpALISWIKXKRQQ,GIGAVLKVLTTGLP{d}ALISWIKXKRQQ{nt:Acet}{ct:Amid},Melittin-A1P,Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,NA,NA
2476,12168695,2002,GIGAVLKVLTTGLpALISWIKRKRQQ,GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{nt:Acet}{ct:Amid},Melittin-A1,Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2486,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2487,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2488,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,1% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2489,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,8% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2490,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,3% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2491,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,37% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2507,12931994,2003,LRLKKRRWKYRVp,LRLKKRRWKYRVP{d}{cyc:N-C},5,Free,Free,Cyclic,Mix,None,13,Antimicrobial,1.4% hemolytic at 100 μg/ml,Human,Protegrin,NA,NA,CCSCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2551,10224074,1999,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,NA,NA
2552,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 1.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2553,10224074,1999,VKLKVyPLKvKLyP,VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 6.2 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2554,10224074,1999,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2555,10224074,1999,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 6.2 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2556,10224074,1999,VKLKVypLKVKLyP,VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2557,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 40 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2558,10224074,1999,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 25 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2559,10224074,1999,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 150 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2560,10224074,1999,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2561,10224074,1999,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 50 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2562,10224074,1999,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 25 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2563,10224074,1999,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 50 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2564,10224074,1999,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 100 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2565,10224074,1999,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2566,10224074,1999,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 150 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2567,10224074,1999,VkLkVyPLKVKLyP,VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K2K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at >200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2568,10224074,1999,VkLkVyPLkVkLyP,VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C},GS14K2K4K9K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at >200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2634,22837667,2013,KWKSFLKTFKSLKKTVLHTLLKAISS,KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid},P,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 5.20 ± 0.02μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2635,22837667,2013,KWKSFLkTFKSLKKTVLHTLLKAISS,KWKSFLK{d}TFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid},K7D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 10.4 ± 0.04μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2636,22837667,2013,KWKSFLKTFKSLKkTVLHTLLKAISS,KWKSFLKTFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid},K14D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 5.20 ± 0.02μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2637,22837667,2013,KWKSFLKTFKSLKKTVLHTLLkAISS,KWKSFLKTFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.10 μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2638,22837667,2013,KWKSFLkTFKSLKkTVLHTLLKAISS,KWKSFLK{d}TFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid},K7D/K14 D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.15μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2639,22837667,2013,KWKSFLKTFKSLKkTVLHTLLkAISS,KWKSFLKTFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K14D/K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.06μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2640,22837667,2013,KWKSFLkTFKSLKkTVLHTLLkAISS,KWKSFLK{d}TFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K7D/K14D/K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 81.31 ± 0.17μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2641,22837667,2013,KWKSFLkTFkSLKkTVLHTLLkAISS,KWKSFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 325.20 ± 0.82μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2642,22837667,2013,KWkSFLkTFkSLKkTVLHTLLkAISS,KWK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K3D/K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC >325.20μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2643,22837667,2013,kWkSFLkTFkSLKkTVLHTLLkAISS,K{d}WK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K1D/K3D/K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC >325.20μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2644,22837667,2013,KWKSFlKTFKSLKKTVLHTLLKAISS,KWKSFL{d}KTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid},L6D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 10.40 ± 0.08μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2645,22837667,2013,KWKSFLKTFKSlKKTVLHTLLKAISS,KWKSFLKTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid},L12D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.03μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2646,22837667,2013,KWKSFLKTFKSLKKTVLHTlLKAISS,KWKSFLKTFKSLKKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L20D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.13μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2647,22837667,2013,KWKSFlKTFKSlKKTVLHTLLKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid},L6D/L12D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 20.81 ± 0.10 μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2648,22837667,2013,KWKSFLKTFKSlKKTVLHTlLKAISS,KWKSFLKTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L12D/L20D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 81.31 ± 0.43μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2649,22837667,2013,KWKSFlKTFKSlKKTVLHTlLKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L6D/L12D/L20D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 162.61 ± 0.19μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2650,22837667,2013,KWKSFlKTFKSlKKTVLHTlLKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L6D/L12D/L17D/L20D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC = 81.31 ± 1.05μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2651,22837667,2013,KWKSFlKTFKSlKKTVLHTllKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTL{d}L{d}KAISS{nt:Acet}{ct:Amid},L6D/L12D/L17D/L20D/L21D,Amidation,Acetylation,Linear,Mix,None,26,Anticancer,MHC >325.20μmol/L,Human,Synthetic α-helical cationic anticancer peptides,NA,NA,CCGGGHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
2677,23652359,2013,KIGAK-D-CF3-Bpg-KIGAKIKIGAKI,KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid},KIGAKI-6D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~7% Hemolysis at 7.5 µM,Human,KIGAKI analog,NA,NA,NA,NA
2678,23652359,2013,KIGAK-D-CF3-Bpg-KIGAKIKIGAKI,KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid},KIGAKI-6D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~10% hemolytic at 60 µM,Human,KIGAKI analog,NA,NA,NA,NA
2681,23652359,2013,KIGAKIK-D-CF3-Bpg-GAKIKIGAKI,KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid},KIGAKI-8D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~5% hemolytic at 7.5 µM,Human,KIGAKI analog,NA,NA,NA,NA
2682,23652359,2013,KIGAKIK-D-CF3-Bpg-GAKIKIGAKI,KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid},KIGAKI-8D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~8% hemolytic at 60 µM,Human,KIGAKI analog,NA,NA,NA,NA
2685,23652359,2013,KIGAKI-12DKIGAKIKIGAK-D-CF3-Bpg-KIGAKI,KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid},KIGAKI-12D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~5% Hemolysis at 7.5 µM,Human,KIGAKI analog,NA,NA,NA,NA
2686,23652359,2013,KIGAKI-12DKIGAKIKIGAK-D-CF3-Bpg-KIGAKI,KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid},KIGAKI-12D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~7% Hemolysis at 60 µM,Human,KIGAKI analog,NA,NA,NA,NA
2689,23652359,2013,KIGAKIKIGAKIK-D-CF3-Bpg-GAKI,KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid},KIGAKI-14D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~6% Hemolysis at 7.5 µM,Human,KIGAKI analog,NA,NA,NA,NA
2690,23652359,2013,KIGAKIKIGAKIK-D-CF3-Bpg-GAKI,KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid},KIGAKI-14D,Amidation,Free,Linear,Mix,CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine,17,Antimicrobial,~7% Hemolysis at 60 µM,Human,KIGAKI analog,NA,NA,NA,NA
2773,19635451,2010,GIGaVLkVLaLISWiKRKR,GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid},Mel-dH,Amidation,Free,Linear,Mix,None,19,Antimicrobial,5% Hemolysis at 0.4 µM,Human,Melittin diastereomeric analog (Honey bee),NA,NA,CCHHHHHHHHHHTGGGGCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
2774,19635451,2010,GIGaVLkVLaLISWiKRKR,GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid},Mel-dH,Amidation,Free,Linear,Mix,None,19,Antimicrobial,12% hemolytic at 23 µM,Human,Melittin diastereomeric analog (Honey bee),NA,NA,CTTTHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
2775,19960443,2010,pslvslvVqLvΔ-But-allothr-I-Hse-dab-K,P{d}S{d}L{d}V{d}S{d}L{d}V{d}VQ{d}LV{d}{nnr:Δ-But}-A{d}L{d}L{d}O{d}T{d}H{d}R{d}-I-{nnr:Hse}-{nnr:dab}-K{nt:β-hydroxyoctanoyl-Δ-But},Tolaasin,Free,β-hydroxyoctanoyl-Δ-But,Linear,Mix,"Δ-But = 2,3-dehydro-2-aminobutyric acid, Hse = L-homoserine, dab = D-2,4-diaminobutyric acid",18,Hemolytic,100% Hemolysis at 0.53 μg/ml,Rat,Tolaasin (Pseudomonas tolaasii),NA,NA,NA,NA
2777,20058937,2010,KKllKLLlKlLK,KKL{d}L{d}KLLL{d}KL{d}LK{ct:Amid},K5L7,Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHTTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2778,20058937,2010,KKllKLLlKlLK,KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid},C6-K5L7,Amidation,Acetylation (CH3(CH2)4CO),Linear,Mix,None,12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHTTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2779,20058937,2010,KKllKLLlKlLK,KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid},C8-K5L7,Amidation,Acetylation (CH3(CH2)6CO),Linear,Mix,None,12,Antimicrobial,19% hemolytic at 100 µM,Human,Synthetic peptides,NA,NA,CTTHHHHTTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2780,20058937,2010,KKllKKLkKlLK,KKL{d}L{d}KKLK{d}KL{d}LK{ct:Amid},K7L5,Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2781,20058937,2010,KKllKKLkKlLK,KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid},C6-K7L5,Amidation,Acetylation (CH3(CH2)4CO),Linear,Mix,nter = Acetylation (CH3(CH2)4CO),12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2782,20058937,2010,KKllKKLkKlLK,KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid},C8-K7L5,Amidation,Acetylation (CH3(CH2)6CO),Linear,Mix,nter = Acetylation (CH3(CH2)6CO),12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2783,20058937,2010,KKklKKLkKkLK,KKK{d}L{d}KKLK{d}KK{d}LK{ct:Amid},K9L3,Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2784,20058937,2010,KKklKKLkKkLK,KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid},C6-K9L3,Amidation,Acetylation (CH3(CH2)4CO),Linear,Mix,nter = Acetylation (CH3(CH2)4CO),12,Antimicrobial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2785,20058937,2010,KKklKKLkKkLK,KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid},C8-K9L3,Amidation,Acetylation (CH3(CH2)6CO),Linear,Mix,nter = Acetylation (CH3(CH2)6CO),12,Antimicrobial,0% hemolytic at 100 µM (non-hemolytic),Human,Synthetic peptides,NA,Non-hemolytic,CTTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2791,20848624,2010,fPVOLfPVOL,F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,HC50 = 17.5±1.07 µM,Human,Gramicidin S,NA,NA,NA,NA
2792,20848624,2010,fPVOLfP-Ada-GOL,F{d}PV{nnr:O}LF{d}P-{nnr:Ada}-G{nnr:O}L{cyc:N-C},GS2,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 10.1±1.11 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2793,20848624,2010,fPVOLfPVO-Ada-A,F{d}PV{nnr:O}LF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS4,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 5.20±1.13 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2794,20848624,2010,fPVO-Ada-AfPVO-Ada-A,F{d}PV{nnr:O}-{nnr:Ada}-AF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS5,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 10.3±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2795,20848624,2010,fP-Ada-GO-Ada-AfP-Ada-GO-Ada-A,F{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-AF{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS6,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 7.55±1.10 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2796,20848624,2010,FP-tBuGly-O-tBuAla-fP-tBuGly-O-tBuAla,FP-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}-F{d}P-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}{cyc:N-C},GS7,Free,Free,Cyclic,Mix,"O = L-Ornithine, tBuGly = tert-butylglycine, tBuAla = tert-butylalanine",10,Antimicrobial,HC50 = 9.30±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2797,20848624,2010,fP-Chg-O-Cha-fP-Chg-O-Cha,F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}-F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}{cyc:N-C},GS8,Free,Free,Cyclic,Mix,"O = L-Ornithine, Chg = Cyclohexylglycine, Cha = Cyclohexylalanine",10,Antimicrobial,HC50 = 9.12±1.13 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2798,20848624,2010,fPOVO,F{d}P{nnr:O}V{nnr:O}{cyc:N-C},GS9,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,Non-hemolytic,Human,Gramicidin S analogue,NA,NA,NA,NA
2799,20848624,2010,fPO-AdaGly-OfPO-Ada-Gly-O,F{d}P{nnr:O}-{nnr:Ada}Gly-{nnr:O}F{d}P{nnr:O}-{nnr:Ada}-Gly-{nnr:O}{cyc:N-C},GS10,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 107±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2827,21300831,2011,GKKllKKlKKllKKG,GKKL{d}L{d}KKL{d}KKL{d}L{d}KKG{nt:Acet}{ct:Amid},MA-d,Amidation,Acetylation,Linear,Mix,None,15,Antimicrobial,1% hemolytic at 3.4mg/ml,Human,Synthetic peptides,NA,NA,CTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
2838,21319749,2011,FVPWFSKFLpRIL,FVPWFSKFLP{d}RIL{ct:Amid},"[Pro3, DPro10]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,0.6% hemolytic at 6 µM,Human,Temporin L Analogues,NA,NA,CCCCGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2845,21319749,2011,fvqwfskflGril,F{d}V{d}Q{d}W{d}F{d}S{d}K{d}F{d}L{d}GR{d}I{d}L{d}{ct:Amid},D-TL,Amidation,Free,Linear,Mix,None,13,Antimicrobial,46% hemolytic at 6 µM,Human,Temporin L Analogues,NA,NA,CHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2846,21319749,2011,lirGlfksfwqvf,L{d}I{d}R{d}GL{d}F{d}K{d}S{d}F{d}W{d}Q{d}V{d}F{d}{ct:Amid},RI-TL,Amidation,Free,Linear,Mix,None,13,Antimicrobial,15% hemolytic at 6 µM,Human,Temporin L Analogues,NA,NA,CTHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
2848,21335383,2011,KKLFKKILKyL,KKLFKKILKY{d}L{ct:Amid},BP138,Amidation,Free,Linear,Mix,None,11,Antimicrobial,7 ±0.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2849,21335383,2011,KKLFKKILKYl,KKLFKKILKYL{d}{ct:Amid},BP139,Amidation,Free,Linear,Mix,None,11,Antimicrobial,23 ±0.9% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2850,21335383,2011,KKLFKKILkYL,KKLFKKILK{d}YL{ct:Amid},BP140,Amidation,Free,Linear,Mix,None,11,Antimicrobial,0± 0% hemolytic at 250 µM (non-hemolytic),Human,Synthetic peptide of BP100,NA,Non-hemolytic,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2851,21335383,2011,KKLFKKIlKYL,KKLFKKIL{d}KYL{ct:Amid},BP141,Amidation,Free,Linear,Mix,None,11,Antimicrobial,4 ±0.3% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2852,21335383,2011,KKLFkKILKYL,KKLFK{d}KILKYL{ct:Amid},BP142,Amidation,Free,Linear,Mix,None,11,Antimicrobial,3± 0.6% Hemolysis at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2853,21335383,2011,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,None,11,Antimicrobial,5± 0.8% Hemolysis at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2854,21335383,2011,KKlFKKILKYL,KKL{d}FKKILKYL{ct:Amid},BP144,Amidation,Free,Linear,Mix,None,11,Antimicrobial,7±0.4% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2855,21335383,2011,KkLFKKILKYL,KK{d}LFKKILKYL{ct:Amid},BP145,Amidation,Free,Linear,Mix,None,11,Antimicrobial,51±0.5% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2856,21335383,2011,KKLFKkILKYL,KKLFKK{d}ILKYL{ct:Amid},BP146,Amidation,Free,Linear,Mix,None,11,Antimicrobial,53 ±1.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2857,21335383,2011,kKLFKKILKYL,K{d}KLFKKILKYL{ct:Amid},BP147,Amidation,Free,Linear,Mix,None,11,Antimicrobial,71±0.4% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2858,21335383,2011,KKLFKKiLKYL,KKLFKKI{d}LKYL{ct:Amid},BP148,Amidation,Free,Linear,Mix,None,11,Antimicrobial,0±0% hemolytic at 250 µM (non-hemolytic),Human,Synthetic peptide of BP100,NA,Non-hemolytic,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2859,21335383,2011,KKlFKKILkYL,KKL{d}FKKILK{d}YL{ct:Amid},BP149,Amidation,Free,Linear,Mix,None,11,Antimicrobial,0±0% hemolytic at 250 µM (non-hemolytic),Human,Synthetic peptide of BP100,NA,Non-hemolytic,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2860,21335383,2011,KKLFKKIlkYL,KKLFKKIL{d}K{d}YL{ct:Amid},BP150,Amidation,Free,Linear,Mix,None,11,Antimicrobial,1±0.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2861,21335383,2011,KklFKkILkYL,KK{d}L{d}FKK{d}ILK{d}YL{ct:Amid},BP151,Amidation,Free,Linear,Mix,None,11,Antimicrobial,1±0.3% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2862,21335383,2011,KKLFKKilkYL,KKLFKKI{d}L{d}K{d}YL{ct:Amid},BP152,Amidation,Free,Linear,Mix,None,11,Antimicrobial,5±1.6% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2863,21335383,2011,kkLfKKILKYL,K{d}K{d}LF{d}KKILKYL{ct:Amid},BP154,Amidation,Free,Linear,Mix,None,11,Antimicrobial,41±6.2% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2864,21335383,2011,KKLFKKIlkyl,KKLFKKIL{d}K{d}Y{d}L{d}{ct:Amid},BP155,Amidation,Free,Linear,Mix,None,11,Antimicrobial,3±0.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2865,21335383,2011,KKLFKKllkyl,KKLFKKL{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP156,Amidation,Free,Linear,Mix,None,11,Antimicrobial,49±1.2% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTTHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
2866,21335383,2011,KKLFKkilkyl,KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP157,Amidation,Free,Linear,Mix,None,11,Antimicrobial,3±1.0% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2867,21335383,2011,KKLFkkilkyl,KKLFK{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP158,Amidation,Free,Linear,Mix,None,11,Antimicrobial,28±2.1% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2868,21335383,2011,KKLfkkilkyl,KKLF{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP159,Amidation,Free,Linear,Mix,None,11,Antimicrobial,58±5.7% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2869,21335383,2011,Kklfkkilkyl,KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP160,Amidation,Free,Linear,Mix,None,11,Antimicrobial,65±1.9% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2870,21335383,2011,Kklfkkilkyl,KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP161,Amidation,Free,Linear,Mix,None,11,Antimicrobial,66±2.9% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2871,21335383,2011,kklfKKILKYL,K{d}K{d}L{d}F{d}KKILKYL{ct:Amid},BP162,Amidation,Free,Linear,Mix,None,11,Antimicrobial,17±0.7% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2872,21335383,2011,kklfkKILKYL,K{d}K{d}L{d}F{d}K{d}KILKYL{ct:Amid},BP163,Amidation,Free,Linear,Mix,None,11,Antimicrobial,8±5.0% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2873,21335383,2011,kklfkkILKYL,K{d}K{d}L{d}F{d}K{d}K{d}ILKYL{ct:Amid},BP164,Amidation,Free,Linear,Mix,None,11,Antimicrobial,0±0% hemolytic at 250 µM (non-hemolytic),Human,Synthetic peptide of BP100,NA,Non-hemolytic,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2874,21335383,2011,kklfkkiLKYL,K{d}K{d}L{d}F{d}K{d}K{d}I{d}LKYL{ct:Amid},BP165,Amidation,Free,Linear,Mix,None,11,Antimicrobial,6 ±0.2% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2875,21335383,2011,kklfkkilKYL,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}KYL{ct:Amid},BP166,Amidation,Free,Linear,Mix,None,11,Antimicrobial,1±0.2% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2876,21335383,2011,kklfkkilkYL,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}YL{ct:Amid},BP167,Amidation,Free,Linear,Mix,None,11,Antimicrobial,21±7.4% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2877,21335383,2011,kklfkkilkyL,K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{ct:Amid},BP168,Amidation,Free,Linear,Mix,None,11,Antimicrobial,3±2.7% hemolytic at 250 µM,Human,Synthetic peptide of BP100,NA,NA,CTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
2909,21343499,2011,EEEEAAAkwklfkkipkflhlakkf,EEEEAAAK{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid},Ac-E4-A3–D-P18,Amidation,Acetylation,Linear,Mix,None,24,Antimcrobial and Hemolytic,~3.5% hemolytic upto 500 µM,Human,Host defense peptides analog (Rana temporaria),NA,NA,CTTTTTHHHHTTTTCSSCSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2942,21729875,2011,GrrkrkWLrrIGkGVkIIGGAALDHL,GR{d}R{d}K{d}R{d}K{d}WLR{d}R{d}IGK{d}GVK{d}IIGGAALDHL{ct:Amid},NRC-03D,Amidation,Free,Linear,Mix,None,26,Anticancer,50% hemolytic at >256 μg/ml,Human,Pleurocidin variant derived from gut and skin of pleuronectid flatfish,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
2960,21820306,2011,tle-K-tle-A-tle-A-tle-A,{nnr:tle}-K-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C},A,Free,Free,Cyclic,Mix,tle = D-Tert-leucine,8,Antimicrobial,HC50 = 17 µM,Human,Synthetic peptides,NA,NA,NA,NA
2961,21820306,2011,Tle-k-Tle-a-Tle-a-Tle-a,{nnr:Tle}-K{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C},B,Free,Free,Cyclic,Mix,Tle = Tert-leucine,8,Antimicrobial,HC50 = 17 µM,Human,Synthetic peptides,NA,NA,NA,NA
2962,21820306,2011,tle-k-tle-A-tle-A-tle-A,{nnr:tle}-K{d}-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C},C,Free,Free,Cyclic,Mix,tle = D-Tert-leucine,8,Antimicrobial,HC50 = 316 µM,Human,Synthetic peptides,NA,NA,NA,NA
2963,21820306,2011,Tle-K-Tle-a-Tle-a-Tle-a,{nnr:Tle}-K-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C},D,Free,Free,Cyclic,Mix,Tle = Tert-leucine,8,Antimicrobial,HC50 = 316 µM,Human,Synthetic peptides,NA,NA,NA,NA
3055,20363271,2010,KLKKLlKKWLKlLKKLLk,KLKKLL{d}KKWLKL{d}LKKLLK{d}{ct:Amid},D3-K9L8W-1,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 150 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3056,20363271,2010,KLKKlLKKWlKLLKkLLK,KLKKL{d}LKKWL{d}KLLKK{d}LLK{ct:Amid},D3-K9L8W-2,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 116 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3057,20363271,2010,KLKkLLKkWLKlLKKlLK,KLKK{d}LLKK{d}WLKL{d}LKKL{d}LK{ct:Amid},D4-K9L8W,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 800 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3058,20363271,2010,KlkKLlKKwLKlLKkLLk,KL{d}K{d}KLL{d}KKW{d}LKL{d}LKK{d}LLK{d}{ct:Amid},D6-K9L8W,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 800 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3059,20363271,2010,KlKkLlKkWlKlLkKlLk,KL{d}KK{d}LL{d}KK{d}WL{d}KL{d}LK{d}KL{d}LK{d}{ct:Amid},D9-K9L8W-1,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 800 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3060,20363271,2010,KLKKLLKKWlkllkkllk,KLKKLLKKWL{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d}K{d}{ct:Amid},D9-K9L8W-2,Amidation,Free,Linear,Mix,None,18,Antimicrobial,HC50 = 154 µM,Human,Synthetic peptide,Random coil,NA,CGGGSHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3077,20603168,2010,GLKkIFKAGLGSLVKGIAAHVAS,GLKK{d}IFKAGLGSLVKGIAAHVAS,E4k,Free,Free,Linear,Mix,None,23,Antimicrobial,LC50 >400 µM,Human,Alyteserin-1c analog,α-helical,NA,CGGGGHHHHTSSSTHHHHSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3079,20603168,2010,GLKkIFKKGLGSLVKGIAAHVAS,GLKK{d}IFKKGLGSLVKGIAAHVAS,"E4k,A8K",Free,Free,Linear,Mix,None,23,Antimicrobial,LC50 >400 µM,Human,Alyteserin-1c analog,α-helical,NA,CCHHHHTTCSSGGGGGTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3081,20603168,2010,GLKkIFKAGLGSLKKGIAAHVAS,GLKK{d}IFKAGLGSLKKGIAAHVAS,"E4k,V14K",Free,Free,Linear,Mix,None,23,Antimicrobial,LC50 >400 µM,Human,Alyteserin-1c analog,α-helical,NA,CCHHHHTTSSCCGGGGGGSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3083,20603168,2010,GLKkIFKAGLGSLVKGIKAHVAS,GLKK{d}IFKAGLGSLVKGIKAHVAS,"E4k,A18K",Free,Free,Linear,Mix,None,23,Antimicrobial,LC50 >400 µM,Human,Alyteserin-1c analog,α-helical,NA,CCTTCGGGTTCTHHHHTCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3132,21497177,2011,GrfKRfRKKfKKLfKKLS,GR{d}F{d}KRF{d}RKKF{d}KKLF{d}KKLS{ct:Amid},BMAP -18-f,Amidation,Free,Linear,Mix,None,18,Antimicrobial,10% Hemolysis at >400 µM,Human,BMAP-27 analog,α-helical,NA,CTTTTTHHHHTTGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)O
3144,21682682,2011,LGRVDIHVWDaVYIRGR,LGRVDIHVWDA{d}VYIRGR,[D-Ala66]-PNT.II,Free,Free,Linear,Mix,None,17,Cytotoxic,3% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCCCCSSSCSSGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3146,21682682,2011,VDIHVWaGV,VDIHVWA{d}GV,D65A-PIP[59-67],Free,Free,Linear,Mix,None,9,Cytotoxic,7.5% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3147,21682682,2011,VDIHVWsGV,VDIHVWS{d}GV,D65S-PIP[59-67],Free,Free,Linear,Mix,None,9,Cytotoxic,1.03% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3148,21682682,2011,VDIHVWeGV,VDIHVWE{d}GV,D65E-PIP[59-67],Free,Free,Linear,Mix,None,9,Cytotoxic,9.9% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3149,21682682,2011,VeIHVWeGV,VE{d}IHVWE{d}GV,"D60,65E-PIP[59-67]",Free,Free,Linear,Mix,None,9,Cytotoxic,2.24% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3171,22965637,2013,ILGKLLkTAAGLLSNL,ILGKLLK{d}TAAGLLSNL{ct:Amid},S7k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 105 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHTTTTTTCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3173,22965637,2013,ILGKLLSTAAkLLSNL,ILGKLLSTAAK{d}LLSNL{ct:Amid},G11k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 42 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3176,22965637,2013,ILGKLLSTAAGLLSkL,ILGKLLSTAAGLLSK{d}L{ct:Amid},N15k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 310 µM,Human,Alyteserin-2a analog,NA,NA,CCCSGGGGTEETTEEC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3177,22965637,2013,ILGKLLKTAAKLLSNL,ILGKLLKTAAKLLSNL{ct:Amid},"S7K,G11K",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 38 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3178,22965637,2013,ILGKLLkTAAkLLSNL,ILGKLLK{d}TAAK{d}LLSNL{ct:Amid},"S7k,G11k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 185 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3180,22965637,2013,ILGKLLSTAAkLLSKL,ILGKLLSTAAK{d}LLSKL{ct:Amid},"G11k,N15K",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 195 µM,Human,Alyteserin-2a analog,NA,NA,CGGGGGHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3184,22965637,2013,ILGKLLSTAWkLLSNL,ILGKLLSTAWK{d}LLSNL{ct:Amid},"A10W,G11k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 21 µM,Human,Alyteserin-2a analog,NA,NA,CTTHHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3186,22965637,2013,ILGKLLSTAWALLSkL,ILGKLLSTAWALLSK{d}L{ct:Amid},"A10W,N15k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 27 µM,Human,Alyteserin-2a analog,NA,NA,CTTHHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3200,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,18% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3201,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,8% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3202,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,5% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3203,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,7% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3204,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,4% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3205,22974815,2013,FVPWFSkFLGRIL,FVPWFSK{d}FLGRIL{ct:Amid},"[Pro3, DLys7]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,2% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3206,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,94% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3207,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,19% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3208,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,19% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3209,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,17% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3210,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,5% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3211,22974815,2013,FVPWFSKfLGRIL,FVPWFSKF{d}LGRIL{ct:Amid},"[Pro3, DPhe8]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,4% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3212,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,9% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3213,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,8% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3214,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,7% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3215,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,3% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3216,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,2% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3217,22974815,2013,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3, DLeu9]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,2% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3218,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,22% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3219,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,16% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3220,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,8% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3221,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,6% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3222,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,4% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3223,22974815,2013,FVPWFSKFLGrIL,FVPWFSKFLGR{d}IL{ct:Amid},"[Pro3, DArg11]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,2% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3224,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,17% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3225,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,14% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3226,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,10% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3227,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,5% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3228,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,4% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3229,22974815,2013,FVPWFSKFLGRiL,FVPWFSKFLGRI{d}L{ct:Amid},"[Pro3, DIle12]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,2% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3230,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,15% Hemolysis at 48 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3231,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,17% Hemolysis at 24 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3232,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,17% Hemolysis at 12 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3233,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,8% Hemolysis at 6 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3234,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,6% Hemolysis at 3 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3235,22974815,2013,FVPWFSKFlGRIl,FVPWFSKFL{d}GRIL{d}{ct:Amid},"[Pro3, DLeu13]TL",Amidation,Free,Linear,Mix,None,13,Antimicrobial,3% Hemolysis at 1.5 µM,Human,Temporin L analog,α-helical,NA,CCCTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3252,23328867,2013,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,THRPPMWSPVWPGGGKLL{d}LKL{d}LK{d}K{d}LLKL{d}LKKK,TfR-lytic hybrid peptide,Free,Free,Linear,Mix,None,32,Anticancer,17% Hemolysis at 100 µM,Mouse,Synthetic peptide,NA,NA,CCTTSSSSSSCCCTHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
3458,8823199,1996,klALKLALKALKAALKLA,K{d}L{d}ALKLALKALKAALKLA,k1/l2,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 7 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3459,8823199,1996,KLalKLALKALKAALKLA,KLA{d}L{d}KLALKALKAALKLA,a3/l4,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 33 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3460,8823199,1996,KLALklALKALKAALKLA,KLALK{d}L{d}ALKALKAALKLA,k5/l6,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 160 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3461,8823199,1996,KLALKLalKALKAALKLA,KLALKLA{d}L{d}KALKAALKLA,a7/l8,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 180 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3462,8823199,1996,KLALKLALkaLKAALKLA,KLALKLALK{d}A{d}LKAALKLA,k9/a10,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 56 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3463,8823199,1996,KLALKLALKAlkAALKLA,KLALKLALKAL{d}K{d}AALKLA,l11/k12,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 540 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3464,8823199,1996,KLALKLALKALKaaLKLA,KLALKLALKALKA{d}A{d}LKLA,a13/a14,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 260 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3465,8823199,1996,KLALKLALKALKAAlkLA,KLALKLALKALKAAL{d}K{d}LA,l15/k16,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 210 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3466,8823199,1996,KLALKLALKALKAALKla,KLALKLALKALKAALKL{d}A{d},l17/a18,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 70 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3582,9048567,1997,GIGAvLKvLTTGLPALiSWIkRKRQQ,GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ{ct:Amid},"[D]-V5,8,I17,K21-melittin",Amidation,Free,Linear,Mix,None,26,Antibacterial,0% Hemolysis at 50 µM,Human,Melittin diastereomers ( venom of the honey bee Apis mellifera),NA,Non-hemolytic,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3583,9048567,1997,GIGAvLKvLTTGLPALiSWIkRKRQQ,GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ,"[D]-V5,8,I17,K21-melittin",Free,Free,Linear,Mix,None,26,Antibacterial,~1-2% Hemolysis at 50 µM,Human,Melittin diastereomers (Apis mellifera),NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3662,8810288,1996,fPVOLfPVOL,F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial,100% Hemolysis at 39 μg/ml,Human,Gramicidin S (Bacillus brevis),NA,NA,NA,NA
3663,8810288,1996,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial,100% Hemolysis at >800 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
3664,8810288,1996,yPKyPK,Y{d}PKY{d}PK{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
3665,8810288,1996,yPVKyPKL,Y{d}PVKY{d}PKL{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)O
3666,8810288,1996,yPVKLyPVKL,Y{d}PVKLY{d}PVKL{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial,100% Hemolysis at 67 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCCSTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3667,8810288,1996,yPVKLKyPKVKL,Y{d}PVKLKY{d}PKVKL{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 250 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3668,8810288,1996,yPVKLKVyPLKVKL,Y{d}PVKLKVY{d}PLKVKL{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial,100% Hemolysis at 6 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCCGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(C)C)C(=O)O
3669,8810288,1996,yPLKVKyPKLKV,Y{d}PLKVKY{d}PKLKV{cyc:N-C},GS12LV,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 92 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
3670,8810288,1996,fPVKLKfPKVKL,F{d}PVKLKF{d}PKVKL{cyc:N-C},GS12F,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 400 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCSSSCTTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
3671,8810288,1996,fPVOLOfPOVOL,F{d}PV{nnr:O}L{nnr:O}F{d}P{nnr:O}V{nnr:O}L{cyc:N-C},GS12FO,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 160 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3672,8810288,1996,fPLOLOfPOLOL,F{d}PL{nnr:O}L{nnr:O}F{d}P{nnr:O}L{nnr:O}L{cyc:N-C},GS12FO/LL,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 170 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3758,10606532,1999,KWllLLKlLlLK,KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid},"[D]L3,4,8,10-K3L8Wn",Amidation,Free,Linear,Mix,None,12,Antimicrobial,31% Hemolysis at 50 µM,Human,Synthetic peptide,NA,NA,CHHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3759,10606532,1999,KLllLWKlLlLK,KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid},"[D]L3,4,8,10-K3L8Wm",Amidation,Free,Linear,Mix,None,12,Antimicrobial,39.4% Hemolysis at 50 µM,Human,Synthetic peptide,NA,NA,CCCHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3760,10606532,1999,KLllLLKlLlWK,KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid},"[D]L3,4,8,10-K3L8Wc",Amidation,Free,Linear,Mix,None,12,Antimicrobial,44.2% Hemolysis at 50 µM,Human,Synthetic peptide,NA,NA,CHHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
3761,10606532,1999,KWllKLKlKlLK,KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid},"[D]L3,4,8,10-K5L6Wn",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCTTSGGGGTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3762,10606532,1999,KLllKWKlKlLK,KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid},"[D]L3,4,8,10-K5L6Wm",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3763,10606532,1999,KLllKLKlKlWK,KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid},"[D]L3,4,8,10-K5L6Wc",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCHHHHSTTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
3764,10606532,1999,KKWlKLKlKlKK,KKWL{d}KLKL{d}KL{d}KK{ct:Amid},"[D]L4,8,10-K7L4Wn",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTCSCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3765,10606532,1999,KKllKWKlKlKK,KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid},"[D]L3,4,8,10-K7L4Wm",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCSCBTTBSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3766,10606532,1999,KKllKLKlKwKK,KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid},"[D]L3,4,8-K7L4Wc",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM (Non hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCTTCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3768,10632060,1999,kΨ[CH2NH]KVVFKVKFKk,K{d}{Ψ[CH2NH]}KVVFKVKFKK{d}{ct:Amid},MP1,Amidation,Free,Linear,Mix,None,11,Antifungal and Antibacterial,0% Hemolysis upto 500 μg/ml (Non hemolytic),Mouse,Synthetic peptide,NA,Non-hemolytic,NA,NA
3769,10632060,1999,KΨ[CH2OCONH]KVVFKVKFKk,K{Ψ[CH2OCONH]}KVVFKVKFKK{d}{ct:Amid},MP6,Amidation,Free,Linear,Mix,None,11,Antifungal and Antibacterial,0% Hemolysis upto 500 μg/ml (Non hemolytic),Mouse,Synthetic peptide,NA,Non-hemolytic,NA,NA
3834,9914515,1999,GFFALIpKIISSPLFKTllSAV,GFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2},"[D]-P7L18,19-Par[1-22]",NH(CH2)2NH2,Free,Linear,Mix,cter = NH(CH2)2NH2,22,Antimicrobial,1% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3835,9914515,1999,KGFFALIpKIISSPLFKTllSAV,KGFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2},"K1[D]-P7L18,19-Par[1-22]",NH(CH2)2NH2,Free,Linear,Mix,cter = NH(CH2)2NH2,23,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3845,10224074,1999,VOLfPVOLfP,VOLF{d}PVOLF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,None,10,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
3846,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 1.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3847,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 6.2 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3848,10224074,1999,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3849,10224074,1999,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 6.2 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3850,10224074,1999,VKLKVypLKVKLyP,VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3851,10224074,1999,vKLKVYPLKVKLyP,V{d}KLKVYPLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 40 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3852,10224074,1999,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 25 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3853,10224074,1999,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 150 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3854,10224074,1999,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3855,10224074,1999,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 50 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3856,10224074,1999,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 25 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3857,10224074,1999,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 50 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3858,10224074,1999,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 100 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3859,10224074,1999,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3860,10224074,1999,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 150 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3861,10224074,1999,VkLkVyPLKVKLyP,VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K2K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at >200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3862,10224074,1999,VkLkVyPLkVkLyP,VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C},GS14K2K4K9K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at >200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3889,11318033,2001,QlLVDlI,QL{d}LVDL{d}I{cyc:N-C},Lichenysin,Free,Free,Cyclic,Mix,None,7,Chelating agent,100% Hemolysis at 15 µM,Human,Bacillus licheniformis,NA,NA,CCSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)O
3943,18568863,2008,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P,GS,Free,Free,Linear,Mix,O = L-Ornithine,10,Antimicrobial,MHC = 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
3944,18568863,2008,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P,GS14,Free,Free,Linear,Mix,None,14,Antimicrobial,MHC = 1.5 μg/ml,Human,Synthetic Peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3945,18568863,2008,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P,GS14K4,Free,Free,Linear,Mix,None,14,Antimicrobial,MHC = 200 μg/ml,Human,Synthetic Peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3946,18568863,2008,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P,GS14K4 V3/A3,Free,Free,Linear,Mix,None,14,Antimicrobial,MHC >800 μg/ml,Human,Synthetic Peptide,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
4137,10606532,1999,KWllLLKlLlLK,KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid},"[D]L3,4,8,10-K3 L8W(n)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,31% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4138,10606532,1999,KLllLWKlLlLK,KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid},"[D]L3,4,8,10-K3 L8W(m)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,39.4% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4139,10606532,1999,KLllLLKlLlWK,KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid},"[D]L3,4,8,10-K3 L8W(c)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,44.2% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4140,10606532,1999,KWllKLKlKlLK,KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid},"[D]L3,4,8,10-K5L6W(n)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4141,10606532,1999,KLllKWKlKlLK,KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid},"[D]L3,4,8,10-K5L6W(m)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4142,10606532,1999,KLllKLKlKlWK,KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid},"[D]L3,4,8,10-K5L6W(c)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4143,10606532,1999,KKwlKLKlKlKK,KKW{d}L{d}KLKL{d}KL{d}KK{ct:Amid},"[D]L4,8,10-K7L4W(n)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4144,10606532,1999,KKllKWKlKlKK,KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid},"[D]L3,4,8,10-K7L4W(m)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4145,10606532,1999,KKllKLKlKwKK,KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid},"[D]L3,4,8-K7L4W(c)",Amidation,Free,Linear,Mix,None,12,Antimicrobial,0% Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4160,15009528,2004,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14KL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4161,15009528,2004,VKLLVyPLKVKLyP,VKLLVY{d}PLKVKLY{d}P{cyc:N-C},GS14LL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCCEEETTEEECCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4162,15009528,2004,VKLVyPLKVKLyP,VKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14FL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
4163,15009528,2004,VKLYyYPLKVKLyP,VKLYY{d}YPLKVKLY{d}P{cyc:N-C},GS14YL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 8 μg/ml,Human,Gramicidin S analog,NA,NA,CCCSSSSSSCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
4164,15009528,2004,VKLNVyPLKVKLyP,VKLNVY{d}PLKVKLY{d}P{cyc:N-C},GS14NL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSCTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4165,15009528,2004,VKLNVyPLKVKLyP,VKLNVY{d}PLKVKLY{d}P{cyc:N-C},GS14GL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCSTTSSSCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4324,23933745,2013,*(KK(x(CYGRKKRRQRRRCYGRKKRRQRRR))LAQLAQ),{nnr:*}KK{nnr:x}CYGRKKRRQRRRCYGRKKRRQRRRLAQLAQ{ct:Amid},Tat-G1L,Amidation,Free,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus,x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",29,Antimicrobial,5 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4325,23933745,2013,(C(YGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRR)xGGGG)(KGKG)KkK*,CYGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRR{nnr:x}GGGGKGKGKK{d}K{nnr:*}{nt:Acet}{ct:Amid},Tat-G2a,Amidation,Acetylation,Linear,Mix,* = 5(6)-carboxyfluorescein amidated to the N-terminus,59,Antimicrobial,<0.3b % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4327,23933745,2013,(C(RQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK)xGG)KkK*,CRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK{nnr:x}GGKK{d}K{nnr:*}{nt:Acet}{ct:Amid},Antp-G1a,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",39,Antimicrobial,1 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4328,23933745,2013,*(KK(x(CRQIKIWFQNRRMKWKKCRQIKIWFQNRRMKWKK))LAQLAQ),{nnr:*}KK{nnr:x}CRQIKIWFQNRRMKWKKCRQIKIWFQNRRMKWKKLAQLAQ{ct:Amid},Antp-G1L,Amidation,Free,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",42,Antimicrobial,1 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4329,23933745,2013,(C(RQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK)xGGGG)(KGKG)KkK*,CRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKKRQIKIWFQNRRMKWKK{nnr:x}GGGGKGKGKK{d}K{nnr:*}{nt:Acet}{ct:Amid},Antp-G2a,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",79,Antimicrobial,<0.3b % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4331,23933745,2013,(C(LLIILRRRIRKQAHAHSKLLIILRRRIRKQAHAHSK)xPSPS)KPSK*,CLLIILRRRIRKQAHAHSKLLIILRRRIRKQAHAHSK{nnr:x}PSPSKPSK{nnr:*}{nt:Acet}{ct:Amid},pVEC-G1b,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",46,Antimicrobial,<0.5b % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4333,23933745,2013,(C(AGYLLGKINKLKALAALAKKILAGYLLGKINKLKALAALAKKIL)xPSPS)KPSK*,CAGYLLGKINKLKALAALAKKILAGYLLGKINKLKALAALAKKIL{nnr:x}PSPSKPSK{nnr:*}{nt:Acet}{ct:Amid},TP10K-G1b,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",54,Antimicrobial,<0.5b % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4335,23933745,2013,(C([VRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP])xGG)KkK*,CVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP{nnr:x}GGKK{d}K{nnr:*}{nt:Acet}{ct:Amid},SAP-G1a,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",43,Antimicrobial,41 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4336,23933745,2013,*(KK(x(CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPP))LAQLAQ),{nnr:*}KK{nnr:x}CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPLAQLAQ{ct:Amid},SAP-G1L,Amidation,Free,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",46,Antimicrobial,79 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4337,23933745,2013,C([VRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP])xGGGG)(KGKG)KkK*,CVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPPVRLPPP{nnr:x}GGGGKGKGKkK{nnr:*}{nt:Acet}{ct:Amid},SAP-G2a,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",87,Antimicrobial,>173c % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4338,23933745,2013,*(KKKK(x(CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPP))LAQLAQLAQLAQ)4,{nnr:*}KKKK{nnr:x}CVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPCVRLPPPVRLPPPVRLPPPLAQLAQLAQLAQ4{ct:Amid},SAP-G2L,Amidation,Free,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",92,Antimicrobial,41 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4340,23933745,2013,(C(PPPLRVPPPLRVPPPLRV)xPSC(PPPLRVPPPLRVPPPLRV)xPSKPSK*,CPPPLRVPPPLRVPPPLRV{nnr:x}PSCPPPLRVPPPLRVPPPLRV{nnr:x}PSKPSK{nnr:*}{nt:Acet}{ct:Amid},SAPr-G1b,Amidation,Acetylation,Linear,Mix,"* = 5(6)-carboxyfluorescein amidated to the N-terminus, x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain",46,Antimicrobial,40 % Hemolysis at 10 µM,Human,Natural Translocating Proteins,α-Helix,NA,NA,NA
4379,24185042,2013,IKLSPkTKDNLKKVLKGAIKGAIAVAKMV,IKLSPK{d}TKDNLKKVLKGAIKGAIAVAKMV{ct:Amid},[E6k]-1B,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,29,Anti-tumor,50 % Hemolysis at 188 ± 8 µM,Human,Congo Clawed Frog Hymenochirus Boettgeri,α-Helix,NA,CCCCTTCSCCSHHHHTTCBCCSSSSBCCC,NA
4380,24185042,2013,IKLSPETKkNLKKVLKGAIKGAIAVAKMV,IKLSPETKK{d}NLKKVLKGAIKGAIAVAKMV{ct:Amid},[D9k]-1B,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,29,Anti-tumor,50 % Hemolysis at >400 µM,Human,Congo Clawed Frog Hymenochirus Boettgeri,α-Helix,NA,CCCCCCCTTCCGGGGGTTBCCSTTSBSCC,NA
4381,24185042,2013,IKLSPkTKkNLKKVLKGAIKGAIAVAKMV,IKLSPK{d}TKK{d}NLKKVLKGAIKGAIAVAKMV{ct:Amid},"[E6k,D9k]-1B",Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,29,Anti-tumor,50 % Hemolysis at 302 ± 21 µM,Human,Congo Clawed Frog Hymenochirus Boettgeri,α-Helix,NA,CTTSSSSHHHHGGGHHHHBCSSTTSBSCC,NA
4454,24147906,2013,allL,A{d}L{d}L{d}L,0,Free,Free,Linear,Mix,lowercase letters correspond to D-amino acids,4,Antibacterial,15.6 ± 3.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCC,NA
4758,24211081,2014,IRIkIrIK,IRIK{d}IR{d}IK{ct:Amid},IK8-2D,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,8,Antimicrobial,10 % Hemolysis at 1600 mg/L,Rabbit,Synthetic,β-Sheet,NA,CCSCCCCC,NA
4763,24211081,2014,IirKIirK,II{d}R{d}KII{d}R{d}K{ct:Amid},Control-4D,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,8,Antimicrobial,10 % Hemolysis at >2000 mg/L,Rabbit,Synthetic,β-Sheet,NA,CGGGTCCC,NA
4773,24277042,2014,GLLKKiKTLL,GLLKKI{d}KTLL{ct:Amid},Lys5 D-Ile6,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,10,Antimicrobial,50 % Hemolysis at 7209 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,CHHHHHHTTC,NA
4774,24277042,2014,GLLKKiKKLL,GLLKKI{d}KKLL{ct:Amid},Lys5 D-Ile6 Lys8,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,10,Antimicrobial,50 % Hemolysis at 1962.4 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,CTHHHHTTTC,NA
4775,24277042,2014,GChaLKR(D-2-Nal)KKLL,G{nnr:Cha}LKR{nnr:D-2-Nal}KKLL{ct:Amid},Cha2 D-2Nal6 Lys8,Amidation,Free,Linear,Mix,"Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine",10,Antimicrobial,50 % Hemolysis at 27 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,NA,NA
4776,24277042,2014,GLLKRiKTLCha,GLLKRiKTL{nnr:Cha}{ct:Amid},Cha2 D-Ile6 Cha10,Amidation,Free,Linear,Mix,Cha = β-cyclohexylalanine,10,Antimicrobial,50 % Hemolysis at 225.6 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,NA,NA
4777,24277042,2014,GLLKR(D-2-Nal)KTLCha,GLLKR{nnr:D-2-Nal}KTL{nnr:Cha}{ct:Amid},D-2Nal6 Cha10,Amidation,Free,Linear,Mix,"Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine",10,Antimicrobial,50 % Hemolysis at 74.3 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,NA,NA
4778,24277042,2014,GLLKKI(D-2-Nal)KKLCha,GLLKKI{nnr:D-2-Nal}KKL{nnr:Cha}{ct:Amid},Lys5 D-2Nal6 Lys8 Cha10,Amidation,Free,Linear,Mix,"Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine",10,Antimicrobial,50 % Hemolysis at 23.6 µM,Human,Venom Of Spider Wasp (Anoplius Samariensis),α-Helix,NA,NA,NA
4785,24805306,2014,KWKSFLkTFKSLKKTVLHTLLKAISS,KWKSFLK{d}TFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid},K7D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,10.41 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4786,24805306,2014,KWKSFLKTFKSLKkTVLHTLLKAISS,KWKSFLKTFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid},K14D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,5.2 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4787,24805306,2014,KWKSFLKTFKSLKKTVLHTLLkAISS,KWKSFLKTFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4788,24805306,2014,KWKSFLkTFKSLKkTVLHTLLKAISS,KWKSFLK{d}TFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid},K7D/K14D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4789,24805306,2014,KWKSFLkTFKSLKKTVLHTLLkAISS,KWKSFLK{d}TFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K14D/K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4790,24805306,2014,KWKSFLkTFKSLKkTVLHTLLkAISS,KWKSFLK{d}TFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K7D/K14D/K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,81.31 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4791,24805306,2014,KWKSFLkTFkSLKkTVLHTLLkAISS,KWKSFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,325.2 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4792,24805306,2014,KWkSFLkTFkSLKkTVLHTLLkAISS,KWK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K3D/K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,>325.2 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4793,24805306,2014,kWkSFLkTFkSLKkTVLHTLLkAISS,K{d}WK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid},K1D/K3D/K7D/K10D/K14D/K22D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,>325.2 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4794,24805306,2014,KWKSFlKTFKSLKKTVLHTLLKAISS,KWKSFL{d}KTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid},L6D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,10.41 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4795,24805306,2014,KWKSFLKTFKSlKKTVLHTLLKAISS,KWKSFLKTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid},L12D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4796,24805306,2014,KWKSFLKTFKSLKKTVLHTlLKAISS,KWKSFLKTFKSLKKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L20D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4797,24805306,2014,KWKSFlKTFKSlKKTVLHTLLKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid},L6D/L12D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,20.81 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4798,24805306,2014,KWKSFLKTFKSlKKTVLHTlLKAISS,KWKSFLKTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L12D/L20D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,81.31 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4799,24805306,2014,KWKSFlKTFKSlKKTVLHTlLKAISS,KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid},L6D/L12D/L20D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,162.61 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4800,24805306,2014,KWKSFlKTFKSlKKTVlHTlLKAISS,KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}LKAISS{nt:Acet}{ct:Amid},L6D/L12D /L17D/L20D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,81.3 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4801,24805306,2014,KWKSFlKTFKSlKKTVlHTllKAISS,KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}L{d}KAISS{nt:Acet}{ct:Amid},L6D/L12D /L17D/L20 D /L21D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,>325.2 % Hemolysis at 650.4 μmol/L,Human,Peptide A12L/A20L,α-Helix,NA,CHHHHHHHHHHHTTTTSSHHHHHCC,NA
4851,24796503,2014,KLLKLLlklLWLKlLLKLLL,KLLKLLL{d}K{d}L{d}LWLKL{d}LLKLLL,Hel 13-5D3,Free,Free,Linear,Mix,Lowercase letters correspond to D-amino acids,18,Pulmonary surfactant,~100 % Hemolysis at 20 µM,Rat,Synthetic,α-Helix,NA,CTHHHHHHHHHHHHHHHHHC,NA
4852,24796503,2014,KLLKLLlklLWlKlLLKlLL,KLLKLLL{d}K{d}L{d}LWL{d}KL{d}LLKL{d}LL,Hel 13-5D5,Free,Free,Linear,Mix,Lowercase letters correspond to D-amino acids,18,Pulmonary surfactant,35 % Hemolysis at 30-50 µM,Rat,Synthetic,α-Helix,NA,CTHHHHHHHHHHHHHHHHHC,NA
4912,24616110,2014,GfGmalkllkkvl,GF{d}GM{d}A{d}L{d}K{d}L{d}L{d}K{d}K{d}V{d}L{d}{ct:Amid},MAC-1/1,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 152 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4914,24616110,2014,lvkkllklamGfG,L{d}V{d}K{d}K{d}L{d}L{d}K{d}L{d}A{d}M{d}GF{d}G{ct:Amid},MAC-1/8,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CHHHHHHHHTCCC,NA
4915,24616110,2014,GFGMALKLAcaKKVL,GFGMALKL{nnr:Aca}KKVL{ct:Amid},MAC-1/24,Amidation,Free,Linear,Mix,Aca = 1-aminocyclohexane carboxylic acid,15,Antimicrobial,50 % Hemolysis at 88 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,NA,NA
4916,24616110,2014,GFGMALKAcaLKKVL,GFGMALK{nnr:Aca}LKKVL{ct:Amid},MAC-1/25,Amidation,Free,Linear,Mix,Aca = 1-aminocyclohexane carboxylic acid,15,Antimicrobial,50 % Hemolysis at 88 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,NA,NA
4917,24616110,2014,GFGMAAcaKLLKKVL,GFGMA{nnr:Aca}KLLKKVL{ct:Amid},MAC-1/26,Amidation,Free,Linear,Mix,Aca = 1-aminocyclohexane carboxylic acid,15,Antimicrobial,50 % Hemolysis at 93 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,NA,NA
4924,24616110,2014,GFGMALKLLKKvL,GFGMALKLLKKV{d}L{ct:Amid},MAC-1/15,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >>200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4925,24616110,2014,GFGMALKLLKkVL,GFGMALKLLKK{d}VL{ct:Amid},MAC-1/11,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >>200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4926,24616110,2014,GFGMALKLLkKVL,GFGMALKLLK{d}KVL{ct:Amid},MAC-1/12,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >>200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4929,24616110,2014,GFGMALkLLKKVL,GFGMALK{d}LLKKVL{ct:Amid},MAC-1/13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >>200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4931,24616110,2014,GFGMaLKLLKKVL,GFGMA{d}LKLLKKVL{ct:Amid},MAC-1/4,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4932,24616110,2014,GFGmALKLLKKVL,GFGM{d}ALKLLKKVL{ct:Amid},MAC-1/19,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at >200 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4933,24616110,2014,GfGMALKLLKKVL,GF{d}GMALKLLKKVL{ct:Amid},MAC-1/6,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 177 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CTTHHHHHHTTTC,NA
4934,24616110,2014,GFkMALKLLKKVL,GFK{d}MALKLLKKVL{ct:Amid},MAC-1/10,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 476 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CCCTTHHHHTTTC,NA
4935,24616110,2014,GfkMALKLLKKVL,GF{d}K{d}MALKLLKKVL{ct:Amid},MAC-1/27,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 391 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CCCTTHHHHTTTC,NA
4936,24616110,2014,aFGMALKLLKKVL,A{d}FGMALKLLKKVL{ct:Amid},MAC-1/28,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 120 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CCCHHHHHHTTTC,NA
4937,24616110,2014,aFKMALKLLKKVL,A{d}FKMALKLLKKVL{ct:Amid},MAC-1/29,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 131 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CCHHHHHHHTTTC,NA
4938,24616110,2014,aFkMALKLLKKVL,A{d}FK{d}MALKLLKKVL{ct:Amid},MAC-1/30,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,13,Antimicrobial,50 % Hemolysis at 476 µM,Human,"Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes",α-Helix,NA,CCHHHHHHHTTTC,NA
5125,25123582,2014,GMASLwAKVLPHVVKLIK,GMASLW{d}AKVLPHVVKLIK,COD-5,Free,Free,Linear,Mix,lowercase letters correspond to D-amino acids,18,Antimicrobial,50 % Hemolysis at >>200 µM,Human,"Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus",α-Helix,NA,CGGGTTTTTCSCSSSCC,NA
5128,25241629,2014,LKLSPKTKkTLKKVLKGAIKGAIAIASMA,LKLSPKTKK{d}TLKKVLKGAIKGAIAIASMA{ct:Amid},[D9k]Hymenochirin-1Pa,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,29,"Antimicrobial, Antitumor",50 % Hemolysis at >400 µM,Human,"Analog Of Hymenochirin-1Pa, Skin Secretions Ofthe Frog Pseudhymenochirus Merlini",α-Helix,NA,CCCCSSCTTTGGGTTTTTCCCCSSSCCCC,NA
5344,25735802,2015,RFRRLRwKTRwRLKKI,RFRRLRW{d}KTRW{d}RLKKI{ct:Amid},PRW4-d,Amidation,Free,Linear,Mix,w = Wd (D-Trp-substituted),16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCCCSCCSSSCCCCCC,NA
5519,26318064,2015,LR(NalNal)LR(NalNal)G,LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},1,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 215 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5521,26318064,2015,LK(NalNal)LR(NalNal)G,LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},3,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5522,26318064,2015,LR(NalNal)LK(NalNal)G,LR{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},4,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5523,26318064,2015,LK(NalNal)LK(NalNal)G,LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},5,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5526,26318064,2015,LR(NalNal)LR(NalNal)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{cyc:N-C},8,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 230 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5527,26318064,2015,LR(NalNal)LR(NalNal)(AhxAhxAhxAhxAhxAhx),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C},9,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid",4,Antimicrobial,50 % Hemolysis at 115 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5528,26318064,2015,LR(NalNal)LR(NalNal)(AocAocAocAocAocAocAocAoc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},10,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 22 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5529,26318064,2015,LR(NalNal)LR(NalNal)(AdcAdcAdcAdcAdcAdcAdcAdcAdcAdc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C},11,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid",4,Antimicrobial,50 % Hemolysis at 15 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5530,26318064,2015,LR(NalNal)LR(NalNal)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{cyc:N-C},12,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,50 % Hemolysis at 265 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5531,26318064,2015,LR(NalNal)LR(NalNal)(εK),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:εK}{cyc:N-C},13,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality",4,Antimicrobial,50 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5532,26318064,2015,LR(NalNal)LR(NalNal)(DabDab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},14,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,50 % Hemolysis at >450 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5533,26318064,2015,LR(NalNal)LR(NalNal)(Abu)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{nnr:Dab}{cyc:N-C},15,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 420 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5534,26318064,2015,LR(NalNal)LR(NalNal)(Dab)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Abu}{cyc:N-C},16,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 255 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5535,26318064,2015,LR(Bip)LR(Bip)G,LR{nnr:Bip}LR{nnr:Bip}G{cyc:N-C},17,Free,Free,Cyclic,Mix,"Bip = 4,4’-biphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 16 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5536,26318064,2015,LR(Dip)LR(Dip)G,LR{nnr:Dip}LR{nnr:Dip}G{cyc:N-C},18,Free,Free,Cyclic,Mix,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 145 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5537,26318064,2015,(AocAoc)R(NalNal)LR(NalNal)G,{nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},19,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5538,26318064,2015,LR(NalNal)(AocAoc)R(NalNal)G,LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},20,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 33 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5539,26318064,2015,(Cha)R(NalNal)LR(NalNal)G,{nnr:Cha}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},21,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 28 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5540,26318064,2015,LR(NalNal)(Cha)R(NalNal)G,LR{nnr:2-Nal}{nnr:Cha}R{nnr:2-Nal}G{cyc:N-C},22,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 60 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5541,26318064,2015,LR(NalNal)(Nle)R(NalNal)G,LR{nnr:2-Nal}{nnr:Nle}R{nnr:2-Nal}G{cyc:N-C},23,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine",4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5542,26318064,2015,PR(NalNal)LR(NalNal)G,PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},24,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5543,26318064,2015,LR(NalNal)PR(NalNal)G,LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C},25,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5544,26318064,2015,LR(NalNal)LRYG,LR{nnr:2-Nal}LRYG{cyc:N-C},26,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,6,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5545,26318064,2015,TR(NalNal)LR(NalNal)G,TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},27,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5546,26318064,2015,LR(NalNal)TR(NalNal)G,LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C},28,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5547,26318064,2015,QR(NalNal)LR(NalNal)G,QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},29,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5548,26318064,2015,LR(DNalNal)(AocAoc)R(NalNal)G,LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},30,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5549,26318064,2015,LR(NalNal)(DAocAoc)R(NaINal)G,LR{nnr:2-Nal}{nnr:D-2-Aoc}R{nnr:2-Nal}G{cyc:N-C},31,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5550,26318064,2015,LR(2NalNal)LR(DNalNal)G,LR{nnr:2-Nal}LR{nnr:D-2-Nal}G{cyc:N-C},32,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5551,26318064,2015,TR(NalNal)IR(NaINal)(AocAocAocAocAocAocAocAoc),TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},33,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5552,26318064,2015,LR(NalNal)(AocAoc)R(NaINal)(DabDab),LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},34,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,3,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5553,26318064,2015,LR(NalNal)LR(NalNal)G,LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},1,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,27 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5555,26318064,2015,LK(NalNal)LR(NalNal)G,LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},3,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,14 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5556,26318064,2015,LR(NalNaI)LK(NalNal)G,LR{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},4,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,19 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5557,26318064,2015,LK(NalNal)LK(NalNal)G,LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},5,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,13 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5560,26318064,2015,LR(NalNal)LR(NalNal)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{cyc:N-C},8,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid",4,Antimicrobial,22 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5561,26318064,2015,LR(NalNal)LR(NalNal)(AhxAhxAhxAhxAhxAhx),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C},9,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid",4,Antimicrobial,75 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5562,26318064,2015,LR(NalNal)LR(NalNal)(AocAocAocAocAocAocAocAoc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},10,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5563,26318064,2015,LR(NalNal)LR(NalNal)(AdcAdcAdcAdcAdcAdcAdcAdcAdcAdc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C},11,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5564,26318064,2015,LR(NalNal)LR(NalNal)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{cyc:N-C},12,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5565,26318064,2015,LR(NalNal)LR(NalNal)(εK),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:εK}{cyc:N-C},13,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality",4,Antimicrobial,51 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5566,26318064,2015,LR(NalNal)LR(NalNal)(DabDab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},14,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5567,26318064,2015,LR(NalNal)LR(NalNal)(Abu)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{nnr:Dab}{cyc:N-C},15,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5568,26318064,2015,LR(NalNal)LR(NalNal)(Dab)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Abu}{cyc:N-C},16,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,12 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5569,26318064,2015,LR(Bip)LR(Bip)G,LR{nnr:Bip}LR{nnr:Bip}G{cyc:N-C},17,Free,Free,Cyclic,Mix,"Bip = 4,4’-biphenyl-L-alanine",5,Antimicrobial,96 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5570,26318064,2015,LR(Dip)LR(Dip)G,LR{nnr:Dip}LR{nnr:Dip}G{cyc:N-C},18,Free,Free,Cyclic,Mix,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,54 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5571,26318064,2015,(AocAoc)R(NalNal)LR(NalNal)G,{nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},19,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5572,26318064,2015,LR(NalNal)(AocAoc)R(NalNal)G,LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},20,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5573,26318064,2015,(Cha)R(NalNal)LR(NalNal)G,{nnr:Cha}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},21,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,99 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5574,26318064,2015,LR(NalNal)(Cha)R(NalNal)G,LR{nnr:2-Nal}{nnr:Cha}R{nnr:2-Nal}G{cyc:N-C},22,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,96 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5575,26318064,2015,LR(NalNal)(Nle)R(NalNal)G,LR{nnr:2-Nal}{nnr:Nle}R{nnr:2-Nal}G{cyc:N-C},23,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine",4,Antimicrobial,35 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5576,26318064,2015,PR(NalNal)LR(NalNal)G,PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},24,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5577,26318064,2015,LR(NalNal)PR(NalNal)G,LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C},25,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5578,26318064,2015,LR(NalNal)LRYG,LR{nnr:2-Nal}LRYG{cyc:N-C},26,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,6,Antimicrobial,19 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5579,26318064,2015,TR(NalNal)LR(NalNal)G,TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},27,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5580,26318064,2015,LR(NalNal)TR(NalNal)G,LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C},28,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5581,26318064,2015,QR(NalNal)LR(NalNal)G,QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},29,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5582,26318064,2015,LR(DNalNal)(AocAoc)R(NalNal)G,LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},30,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,92 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5583,26318064,2015,LR(NalNal)(DAocAoc)R(NaINal)G,LR{nnr:2-Nal}{nnr:D-2-Aoc}R{nnr:2-Nal}G{cyc:N-C},31,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5584,26318064,2015,LR(NalNal)LR(DNalNal)G,LR{nnr:2-Nal}LR{nnr:D-2-Nal}G{cyc:N-C},32,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5585,26318064,2015,TR(NalNal)IR(NaINal)(AocAocAocAocAocAocAocAoc),TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},33,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,10 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5586,26318064,2015,LR(NalNal)(AocAoc)R(NaINal)(DabDab),LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},34,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,3,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5948,25495219,2015,dab-Dab-Dab-L-f-Dab-Dab-L,{nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid},29,Amidation,Free,Linear,Mix,Dab = diaminobutyric acid,3,Antimicrobial,<2 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
5949,25495219,2015,FA-dab-Dab-Dab-L-f-Dab-Dab-L,{nnr:FA}-{nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid},17,Amidation,Free,Linear,Mix,"FA = fatty acid, Dab = diaminobutyric acid",3,Antimicrobial,1.79 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,Random coil,NA,NA,NA
5950,25495219,2015,R1 -dab-[Dab-Dab-L-f-Dab-Dab-L],{nnr:R1}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L],13,Free,Free,Cyclic,Mix,"R1 = 4-methylhexanoyl, Dab = diaminobutyric acid",3,Antimicrobial,2.02 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
5951,25495219,2015,Fmoc-dab-[Dab-Dab-L-f-Dab-Dab-L],{conj:Fmoc}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L],12,Free,Free,Cyclic,Mix,"Dab = diaminobutyric acid, Fmoc = fluorenylmethyloxycarbonyl",3,Antimicrobial,41 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
5952,25495219,2015,R3 -dab-Dab-Dab-L-f-Dab-Dab-L,{nnr:R3}-{nnr:dab}-{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L{ct:Amid},19,Amidation,Free,Linear,Mix,"R3 = myristyl, Dab = diaminobutyric acid",3,Antimicrobial,76.9 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
6016,26574005,2016,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,None,18,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6017,26574005,2016,KKLFKkilkyl,KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid},BP157,Amidation,Free,Linear,Mix,None,18,Antimicrobial,8 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6024,26574005,2016,KKLFKKiLKYL,KKLFKKI{d}LKYL{ct:Amid},BP207,Amidation,Free,Linear,Mix,None,18,Antimicrobial,Not determined,Human,Bp Analogue,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6028,26574005,2016,KKLfKKILRYL,KKLF{d}KKILRYL{ct:Amid},BP211,Amidation,Free,Linear,Mix,None,18,Antimicrobial,43 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6029,26574005,2016,KKL(D2-nal)KKILKYL,KKL{nnr:D2-nal}KKILKYL{ct:Amid},BP212,Amidation,Free,Linear,Mix,D2-nal = D-2-nal,18,Antimicrobial,85 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,NA,NA
6030,26574005,2016,KKLFKkilryl,KKLFKK{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid},BP213,Amidation,Free,Linear,Mix,None,18,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Bp Analogue,NA,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6120,26918268,2016,Fmoc-k(iPr)(Boc),{conj:Fmoc}-K{d}{nnr:iPr}{nnr:Boc}{ct:OH},gA3K(iPr),OH,Free,Linear,Mix,"K{d} = D-lysine, fmoc = 9-fluorenylmethoxycarbonyl, iPr = Isopropyl group, Boc = ε-amino group of the lysine side chain",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6121,26918268,2016,Fmoc-k(Cy)(Boc),{conj:Fmoc}-K{d}{nnr:Cy}{nnr:Boc}{ct:OH},gA3K(Cy),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, Cy = Cyclohexyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,55 % Hemolysis at 20 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6122,26918268,2016,Fmoc-k(CyMe)(Boc),{conj:Fmoc}-K{d}{nnr:CyMe}{nnr:Boc}{ct:OH},gA3K(CyMe),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, CyMe = Cyclohexylmethyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<90 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6123,26918268,2016,Fmoc-k(Bn)(Boc),{conj:Fmoc}-K{d}{nnr:Bn}{nnr:Boc}{ct:OH},gA3K(Bn),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, Bn = Benzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<90 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6124,26918268,2016,Fmoc-k(2pyr)(Boc),{conj:Fmoc}-K{d}{nnr:2pyr}{nnr:Boc}{ct:OH},gA3K(2pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 2pyr = 2-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6125,26918268,2016,Fmoc-k(3pyr)(Boc),{conj:Fmoc}-K{d}{nnr:3pyr}{nnr:Boc}{ct:OH},gA3K(3pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 3pyr = 3-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6126,26918268,2016,Fmoc-k(4pyr)(Boc),{conj:Fmoc}-K{d}{nnr:4pyr}{nnr:Boc}{ct:OH},gA3K(4pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 4pyr = 4-Pyridyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6127,26918268,2016,Fmoc-k(4AMBn)(Boc),{conj:Fmoc}-K{d}{nnr:4AMBn}{nnr:Boc}{ct:OH},gA3K(4AMBn),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 4AMBn = 4-Aminomethylbenzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<25 % Hemolysis at 75 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6192,26795535,2016,RGLRRLGRKIAHGVKKYGptvlriiria,RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid},SMAP-29-D1,Amidation,Free,Linear,Mix,i = D-Isoleucine,28,"Antimicrobial, Anti-MRSA, Anti-inflammatory",10 % Hemolysis at 110 µM,Human,Smap-29 Diastereomeric Peptides,α-Helix,NA,CCHHHHHHHHCSSTTSHHHHHHCCCCC,NA
6193,26795535,2016,RGLRRLGRKIAHGVKKYGptvlriiria,RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid},SMAP-29-D2,Amidation,Free,Linear,Mix,i = d-allo-isoleucine,28,"Antimicrobial, Anti-MRSA, Anti-inflammatory",10 % Hemolysis at 217.5 µM,Human,Smap-29 Diastereomeric Peptides,α-Helix,NA,NA,NA
6564,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 1 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6565,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6566,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6567,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6568,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6569,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6570,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6571,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6572,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6573,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<10 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6574,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6575,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6576,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6577,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6578,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6579,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6580,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6581,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6582,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6686,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,30 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6687,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,0 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6688,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,53 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6689,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,51 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6690,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,51 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6691,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6692,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6693,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,77 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6694,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,2 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6695,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,10 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6696,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6697,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6698,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,19 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6699,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6700,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6701,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,61 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6702,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,68 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6703,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,9 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6704,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,8 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6705,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,35 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6706,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,21 ± 13 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6707,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,Mix,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6738,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,38 ± 7 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6739,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,4 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6740,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,64 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6741,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,54 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6742,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,56 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6743,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6744,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6745,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,81 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6746,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,4 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6747,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,14 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6748,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6749,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6750,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,34 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6751,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,28 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6752,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6753,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6754,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6755,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,16 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6756,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,13 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6757,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,46 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6758,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6811,27900727,2016,IDWKKllDAAKQIl,IDWKKL{d}L{d}DAAKQIL{d}{ct:Amid},D-lys-MPI,Amidation,Free,Linear,Mix,l = D-Lys lowercase letters correspond to D-amino acids,15,Antimicrobial,0 % Hemolysis at 256 µM,Human,Polybia-Mpi Analogues,α-Helical,Non-hemolytic,CCHHHHHHHHTTTC,NA
6960,27992168,2017,dabDabDabLfDabDabL,{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid},GZ3.27,Amidation,R1 = 4-methylhexanoyl,Linear,Mix,"R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid",3,Antimicrobial,1.8 ± 0.45 % Hemolysis at 100 µM,Mouse,Lipopeptide,NA,NA,NA,NA
6961,27992168,2017,CdabDabDabLfDabDabL,C{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid},GZ3.163,Amidation,R1 = 4-methylhexanoyl,Linear,Mix,"R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid",4,Antimicrobial,4.3 ± 0.42 % Hemolysis at 100 µM,Mouse,Battacin Lipopeptide Analogue,NA,NA,NA,NA
6962,27992168,2017,dabDabDabLfDabDabLC,{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}LC{nt:R1 = 4-methylhexanoyl}{ct:Amid},GZ3.160,Amidation,R1 = 4-methylhexanoyl,Linear,Mix,"R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid",4,Antimicrobial,2.8 ± 0.30 % Hemolysis at 100 µM,Mouse,Battacin Lipopeptide Analogue,NA,NA,NA,NA
6963,27992168,2017,dabDab(C)DabLfDabDabL,{nnr:dab}{nnr:Dab}C{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R1 = 4-methylhexanoyl}{ct:Amid},GZ3.155,Amidation,R1 = 4-methylhexanoyl,Linear,Mix,"R1 = 4-methylhexanoyl, Dab = 2,4-diaminobutyric acid, dab = D-2,4-diaminobutyric acid",4,Antimicrobial,2.2 ± 0.93 % Hemolysis at 100 µM,Mouse,Battacin Lipopeptide Analogue,NA,NA,NA,NA
7165,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 8 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7166,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 15.6 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7167,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 31.2 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7168,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 62.5 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7169,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 125 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7170,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7171,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7172,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",<10 % Hemolysis at 1000 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7424,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,0.8±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7425,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.2±0.0 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7426,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.4±0.1 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7427,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,1.1±0.0 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7428,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,1.7±0.0 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7429,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.4±0.0 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7430,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.2±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7431,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.8±0.1 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7432,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.8±0.1 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7433,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,0.8±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7434,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.0±0.1 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7435,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,0.9±0.0 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
7436,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,21(±4) % Hemolysis at 50 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7437,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,7(±3) % Hemolysis at 25 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7438,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,6(±3) % Hemolysis at 12.5 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7439,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,3(±2) % Hemolysis at 6.25 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7440,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,1(±1) % Hemolysis at 3.125 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7441,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,7(±4) % Hemolysis at 50 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7442,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,5(±3) % Hemolysis at 25 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7443,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,5(±2) % Hemolysis at 12.5 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7444,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,1(±2) % Hemolysis at 6.25 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7445,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,0(±1) % Hemolysis at 3.125 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7446,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,37(±1) % Hemolysis at 50 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7447,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,20(±3) % Hemolysis at 25 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7448,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,7(±1) % Hemolysis at 12.5 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7449,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,4(±2) % Hemolysis at 6.25 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7450,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,2(±1) % Hemolysis at 3.125 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7481,29163899,2017,cWkKkC,C{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid},RH1,Amidation,Free,Cyclic,Mix,None,6,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7482,29163899,2017,CwWkKkC,CW{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid},RH2,Amidation,Free,Cyclic,Mix,None,7,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7483,29163899,2017,cWwKkKkC,C{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH3,Amidation,Free,Cyclic,Mix,None,8,Antimicrobial,MHC at 500 μg/ml,Human,Camp,β-Sheet,NA,CCSSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7484,29163899,2017,CwWwKkKkC,CW{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH4,Amidation,Free,Cyclic,Mix,None,9,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSSCSSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7485,29163899,2017,CwWwKkKkKC,CW{d}WW{d}KK{d}KK{d}KC{cyc:N-C}{ct:Amid},RH5,Amidation,Free,Cyclic,Mix,None,10,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCSTTSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7486,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,CEEETTTEEEC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7487,29163899,2017,cWwWwKkKkKkC,C{d}WW{d}WW{d}KK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH7,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,CCSSCTTSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7488,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6m,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-meta-xylene",11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7489,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6o,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-ortho-xylene.",11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7490,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6ss,Amidation,Free,Cyclic,Mix,Cyclized with disulfide bridge,11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7491,29163899,2017,CfFfFkKkKkC,CF{d}FF{d}FK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH8,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 500 μg/ml,Human,Camp,β-Sheet,NA,CCCSSSSSCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7492,29163899,2017,ClLlLkKkKkC,CL{d}LL{d}LK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH9,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at >2000 μg/ml,Human,Camp,β-Sheet,NA,CCSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
7493,29163899,2017,CkKkWwWwKkC,CK{d}KK{d}WW{d}WW{d}KK{d}C{cyc:N-C}{ct:Amid},RH10,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CTTCCCCCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7494,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7495,29163899,2017,cWwKkKkKwWc,C{d}WW{d}KK{d}KK{d}KW{d}WC{d}{cyc:N-C}{ct:Amid},dRH11,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7496,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11m,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-meta-xylene",11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7497,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11o,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-ortho-xylene.",11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7498,29163899,2017,CkWkWkWkWkC,CK{d}WK{d}WK{d}WK{d}WK{d}C{cyc:N-C}{ct:Amid},RH12,Amidation,Free,Cyclic,Mix,None,10,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCSSCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7499,29163899,2017,CWwKkKkKwWwC,CWW{d}KK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid},RH13,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCSCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7500,29163899,2017,cwWkKkKkWwWc,C{d}W{d}WK{d}KK{d}KK{d}WW{d}WC{d}{cyc:N-C}{ct:Amid},dRH13,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,CCSCCCCSCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7501,29163899,2017,CwWkKkKwWwC,CW{d}WK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid},RH14,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 8 μg/ml,Human,Camp,β-Sheet,NA,CCSCSCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7502,29163899,2017,CwKkKkKkWwC,CW{d}KK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH15,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CCCCCCCCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7503,29163899,2017,ClLkKkKkLlC,CL{d}LK{d}KK{d}KK{d}LL{d}C{cyc:N-C}{ct:Amid},RH16,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at >2000 μg/ml,Human,Camp,β-Sheet,NA,CCCCCBTTBCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7504,29163899,2017,CWWKKKKKWWC,CWWKKKKKWWC{cyc:N-C}{ct:Amid},RH17,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7505,29163899,2017,C(Me)wWkKkKkW(Me)wC,C{nnr:Me}W{d}WK{d}KK{d}KK{d}W{nnr:Me}W{d}C{cyc:N-C}{ct:Amid},RH18,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 8 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7506,29163899,2017,Cw(Me)WkKkKkW(Me)wC,CW{d}{nnr:Me}WK{d}KK{d}KK{d}W{nnr:Me}W{d}C{cyc:N-C}{ct:Amid},RH19,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7507,29163899,2017,CwW(Me)kKkK(Me)kWwC,CW{d}W{nnr:Me}K{d}KK{d}K{nnr:Me}K{d}WW{d}C{cyc:N-C}{ct:Amid},RH20,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7928,28833783,2017,IDWKKLLKAAKPraIL,IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid},C-MPI-1,Amidation,Acetylation,Cyclic,Mix,Pra = L-propargylglycine,16,Antimicrobial,30 % Hemolysis at 50 µM,Human,Mpi Analogs,α-Helical,NA,NA,NA
7929,28833783,2017,IDWKKLLKAAKPraIL,IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid},C-MPI-1,Amidation,Acetylation,Cyclic,Mix,Pra = L-propargylglycine,16,Antimicrobial,35 % Hemolysis at 150 µM,Human,Mpi Analogs,α-Helical,NA,NA,NA
7931,28981608,2017,ILGTILGLLkSL,ILGTILGLLK{d}SL{ct:Amid},D-lys-CP,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,12,Antimicrobial,0 % Hemolysis at <20 µM,Human,D-Lysine Substituted Derivative,α-Helical,Non-hemolytic,CCHHHHHHHHHC,NA
7934,28981608,2017,ILGTILGLLkSL,ILGTILGLLK{d}SL{ct:Amid},D-lys-CP,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,12,Antimicrobial,0 % Hemolysis at >30 µM,Human,D-Lysine Substituted Derivative,α-Helical,Non-hemolytic,CCHHHHHHHHHC,NA
7937,28981608,2017,ILGTILGLLkSL,ILGTILGLLK{d}SL{ct:Amid},D-lys-CP,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,12,Antimicrobial,0 % Hemolysis at <70 µM,Human,D-Lysine Substituted Derivative,α-Helical,Non-hemolytic,CCHHHHHHHHHC,NA
7940,28981608,2017,ILGTILGLLkSL,ILGTILGLLK{d}SL{ct:Amid},D-lys-CP,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,12,Antimicrobial,0.2 % Hemolysis at 130 µM,Human,D-Lysine Substituted Derivative,α-Helical,NA,CCHHHHHHHHHC,NA
8293,38062792,2023,kkLLkLLkLLL,K{d}K{d}LLK{d}LLK{d}LLL,ln69,Free,Free,Linear,Mix,k = D-lysine,11,Antimicrobial,MHC at 1000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8295,38062792,2023,NlysKLLKLLkLLNleu,{nnr:Nlys}KLLKLLK{d}LL{nnr:Nleu},EB2,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8297,38062792,2023,KKLLKNleuNLeuNlysNleuNleuNleu,KKLLK{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nleu},EB4,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8298,38062792,2023,NlysNlysNleuNleuNlysLLKLLL,{nnr:Nlys}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}LLKLLL,EB5,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at 1000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8299,38062792,2023,NlysNlysLLNlysLLKLLL,{nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LLKLLL,EB6,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at 250 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8300,38062792,2023,NlysNlysLLNlysLLNlysLLL,{nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LL{nnr:Nlys}LLL,EB7,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8302,38062792,2023,KNlysLNleuKNleuLNlysLNleuL,K{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}L,EB9,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8303,38062792,2023,NlysKNleuLNlysLNleuKNleuLNleu,{nnr:Nlys}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nleu},EB10,Free,Free,Linear,Mix,"NLys = (lysine-like residue), NLeu = (leucine-like residue)",11,Antimicrobial,MHC at >2000 μg/ml,Human,Peptide−Peptoid Hybrids,α-Helical,NA,NA,NA
8328,37797458,2023,VDKPPYLPRPRPPRrIYNr,VDKPPYLPRPRPPRR{d}IYNR{d}{ct:Amid},Oncocin112(8),Amidation,Free,Linear,Mix,None,21,Antimicrobial,3.3 % Hemolysis at 800 μg/ml,Human,Analogues Of Oncocin,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
8329,37797458,2023,VDK(Hyp)(Hyp)YLPRPR(Hyp)PRrIYNr,VDK{nnr:Hyp}{nnr:Hyp}YLPRPR{nnr:Hyp}PRR{d}IYNR{d}{ct:Amid},9,Amidation,Free,Linear,Mix,Hyp = trans-4-Hydroxy-l-proline,17,Antimicrobial,1.2 % Hemolysis at 800 μg/ml,Human,Analogues Of Oncocin,NA,NA,NA,NA
8330,37797458,2023,VDK(Dfp)(Dfp)YLPRPR(Dfp)PRrIYNr,VDK{nnr:Dfp}{nnr:Dfp}YLPRPR{nnr:Dfp}PRR{d}IYNR{d}{ct:Amid},10,Amidation,Free,Linear,Mix,"Dfp = 4,4-Difluoro-l-proline",17,Antimicrobial,0.2 % Hemolysis at 800 μg/ml,Human,Analogues Of Oncocin,NA,NA,NA,NA
8473,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.19 µM,Human,Synthetic,α-Helical,NA,NA,NA
8474,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.39 µM,Human,Synthetic,α-Helical,NA,NA,NA
8475,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.78 µM,Human,Synthetic,α-Helical,NA,NA,NA
8476,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 1.56 µM,Human,Synthetic,α-Helical,NA,NA,NA
8477,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 3.12 µM,Human,Synthetic,α-Helical,NA,NA,NA
8478,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 6.25 µM,Human,Synthetic,α-Helical,NA,NA,NA
8479,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helical,NA,NA,NA
8480,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 25 µM,Human,Synthetic,α-Helical,NA,NA,NA
8481,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 50 µM,Human,Synthetic,α-Helical,NA,NA,NA
8482,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 100 µM,Human,Synthetic,α-Helical,NA,NA,NA
8672,29077406,2017,fPVOL-fPVOL,F{d}PV{nnr:O}L-F{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,"O = Ornithine, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 12 μg/ml,Human,Aneurinibacillus Migulanus,C2-symmetric antiparallel β-Sheet,NA,NA,NA
8673,29077406,2017,f(Dyp)VOLfPVOL,F{d}{nnr:Dyp}V{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS mimetic 15,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 85 μg/ml,Human,Gs Derivative Synthesized,β-Turn,NA,NA,NA
8674,29077406,2017,D-Hot═Tap-V-O-L-f-P-V-O-L,{nnr:D-Hot═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C},dimethylketal modified GS analogue,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",9,Antimicrobial,90 % Hemolysis at >200 μg/ml,Human,Dihydroxylated Dipeptide D-Hot═Tap (D-Hydroxythreonine═Thiaproline With The “═” Representing The Two Covalent Ring Connections),twisted β-Sheet structure,NA,NA,NA
8675,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-decyliden)]═Tap-V-O-L-f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-decyliden)]═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 17,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 38 μg/ml,Human,Gs Analogue Modified With A C8- Alkyl Chain,twisted β-Sheet structure,NA,NA,NA
8676,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-pentadecyliden)]═Tap-V-O-L- f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-pentadecyliden)]═Tap}-V-{nnr:O}-L- F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 18,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 6 μg/ml,Human,Gs Analogue 18 Modified With A C13-Alkyl Chain,twisted β-Sheet structure,NA,NA,NA
8677,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-8-pentadecyliden)]═Tap-V-O L-f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-8-pentadecyliden)]═Tap}-V-{nnr:O}L-F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 19,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 5 μg/ml,Human,Gs Analogue Modified With Two C7-Alkyl Chains,twisted β-Sheet structure,NA,NA,NA
8753,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.61 ± 0.25 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8754,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.95 ± 0.45 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8755,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.77 ± 0.81 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8756,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,1.28 ± 1.65 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8757,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,26.5 ± 4.45 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8758,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,8.34 ± 1.80 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8759,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,64.2 ± 3.28 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8760,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,25.3 ± 4.15 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8761,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,2.25 ± 2.18 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8762,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.80 ± 0.40 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8763,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,1.12 ± 0.47 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8764,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,93.9 ± 7.57 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8765,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,24.9 ± 2.71 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8766,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5}{ct:Amid},Benzoyl-Pat,Amidation,R5 = benzoyl,Linear,Mix,"R5 = benzoyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.70 ± 0.34 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8767,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6}{ct:Amid},Cbz-Pat,Amidation,R6 = benzyloxycarbonyl,Linear,Mix,"R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.65 ± 0.29 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8768,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7}{ct:Amid},Cha-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,1.63 ± 0.40 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8769,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7}{ct:Amid},ChaPhe2DLeu7Phe8-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,34.6 ± 0.91 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8770,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:{nt:R4}{ct:Amid}},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.08 ± 0.85 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8771,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.79 ± 0.63 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8772,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.18 ± 0.68 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8773,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.60 ± 1.35 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8774,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,4.86 ± 1.05 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8775,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,2.03 ± 0.44 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8776,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,18.8 ± 2.44 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8777,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,6.18 ± 2.48 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8778,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.73 ± 0.50 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8779,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.41 ± 0.53 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8780,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.69 ± 0.64 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8781,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,73.4 ± 7.59 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8782,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,10.0 ± 1.03 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8783,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid},Benzoyl-Pat,Amidation,R5 = benzoyl,Linear,Mix,"R5 = benzoyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,1.14 ± 1.05 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8784,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid},Cbz-Pat,Amidation,R6 = benzyloxycarbonyl,Linear,Mix,"R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.54 ± 0.70 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8785,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},Cha-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.65 ± 0.62 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8786,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},ChaPhe2DLeu7Phe8-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,11.02 ± 0.99 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8787,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.41 ± 0.58 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8788,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.32 ± 0.74 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8789,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.78 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8790,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.49 ± 1.22 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8791,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.39 ± 0.55 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8792,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.39 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8793,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,5.10 ± 1.26 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8794,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.91 ± 0.25 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8795,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.80 ± 0.68 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8796,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.38 ± 0.62 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8797,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.44 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8798,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,broad Antibacterial activity,37.2 ± 8.62 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8799,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,5.06 ± 1.14 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8800,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid},Benzoyl-Pat,Amidation,R5 = benzoyl,Linear,Mix,"R5 = benzoyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.71 ± 0.82 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8801,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid},Cbz-Pat,Amidation,R6 = benzyloxycarbonyl,Linear,Mix,"R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.41 ± 0.67 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8802,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},Cha-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.33 ± 0.83 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8803,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},ChaPhe2DLeu7Phe8-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,2.46 ± 0.34 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8804,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.48 ± 0.64 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8805,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,−0.17 ± 0.19 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8806,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.18 ± 0.54 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8807,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.28 ± 1.11 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8808,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.96 ± 0.59 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8809,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.14 ± 0.20 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8810,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.99 ± 0.31 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8811,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.93 ± 0.45 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8812,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.52 ± 0.58 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8813,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.37 ± 0.62 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8814,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.86 ± 0.72 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8815,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,14.3 ± 4.25 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8816,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,1.25 ± 0.71 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8817,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R5 = benzoyl}{ct:Amid},Benzoyl-Pat,Amidation,R5 = benzoyl,Linear,Mix,"R5 = benzoyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.22 ± 0.17 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8818,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R6 = benzyloxycarbonyl}{ct:Amid},Cbz-Pat,Amidation,R6 = benzyloxycarbonyl,Linear,Mix,"R6 = benzyloxycarbonyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.77 ± 0.15 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8819,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},Cha-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.55 ± 0.75 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8820,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R7 = 3-cyclohexylalanyl}{ct:Amid},ChaPhe2DLeu7Phe8-Pat,Amidation,R7 = 3-cyclohexylalanyl,Linear,Mix,"R7 = 3-cyclohexylalanyl, Dab = 2,4-diaminobutyric acid",9,Antimicrobial,0.60 ± 0.18 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8821,29140694,2017,fPFfNQYVOL,F{d}PFF{d}NQYV{nnr:O}L{cyc:N-C},Tyrocidine A,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antimicrobial,100 % Hemolysis at 5 μg/ml,Mouse,Bacillus Brevis,β-Hairpin,NA,NA,NA
8822,29140694,2017,fBE2FfNQYVOL,F{d}{nnr:BE2}FF{d}NQYV{nnr:O}L{cyc:N-C},Tyrocidine A analogue AC3.27,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antifungal,~60 % Hemolysis at 38 μg/ml,Mouse,Synthetic Analogue Of Tyrocidine A,β-Hairpin,NA,NA,NA
8823,29140694,2017,fBE2FfNKYVOL,F{d}{nnr:BE2}FF{d}NKYV{nnr:O}L{cyc:N-C},Tyrocidine A analogue AC3.28,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antifungal,~60 % Hemolysis at 38 μg/ml,Mouse,Synthetic Analogue Of Tyrocidine A,β-Hairpin,NA,NA,NA
8824,29188836,2017,fPVRLfPVRL,F{d}PVRLF{d}PVRL{cyc:N-C},GS-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 10.03±0.49 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8825,29188836,2017,aPVRLfPVRL,A{d}PVRLF{d}PVRL{cyc:N-C},MGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 67.18±2.94 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CCGGGTSTTSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
8826,29188836,2017,fAVRLfPVRL,F{d}AVRLF{d}PVRL{cyc:N-C},MGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 55.03±1.77 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CHHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8827,29188836,2017,fPARLfPVRL,F{d}PARLF{d}PVRL{cyc:N-C},MGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 30.56±1.80 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
8828,29188836,2017,fPVALfPVRL,F{d}PVALF{d}PVRL{cyc:N-C},MGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 14.41±0.51 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8829,29188836,2017,fPVRAfPVRL,F{d}PVRAF{d}PVRL{cyc:N-C},MGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 36.33±1.98 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8830,29188836,2017,aPVRLaPVRL,A{d}PVRLA{d}PVRL{cyc:N-C},DGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 137.40±6.20 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
8831,29188836,2017,fAVRLfAVRL,F{d}AVRLF{d}AVRL{cyc:N-C},DGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 199.90±9.80 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8832,29188836,2017,fPARLfPARL,F{d}PARLF{d}PARL{cyc:N-C},DGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 88.95±7.51 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)O
8833,29188836,2017,fPVALfPVAL,F{d}PVALF{d}PVAL{cyc:N-C},DGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8834,29188836,2017,fPVRAfPVRA,F{d}PVRAF{d}PVRA{cyc:N-C},DGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
8870,29280948,2017,KWKSFLKTFKSAKkTVLHTALKAISS,KWKSFLKTFKSAKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid},K14D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 125 µM,Human,V13K Analogs,NA,Low hemolytic,NA,NA
8871,29280948,2017,KWKSFLKTFKsAKkTVLHTALKAISS,KWKSFLKTFKS{d}AKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid},S11D/K14D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 125 µM,Human,V13K Analogs,NA,Low hemolytic,NA,NA
8872,29280948,2017,KWKSFLKTFKSAKktVLHTALKAISS,KWKSFLKTFKSAKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid},K14D/T15D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 250 µM,Human,V13K Analogs,NA,Low hemolytic,CHHHHTHHHHHHCHHHHHHHHHHSCC,NA
8873,29280948,2017,KWKSFLKTFKsAKktVLHTALKAISS,KWKSFLKTFKS{d}AKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid},S11D/K14D/T15D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 250 µM,Human,V13K Analogs,NA,Low hemolytic,CHHHHTHHHHCSSSTTGGGGGGTTCC,NA
8874,29280948,2017,KWKSFLKTFKSaKKTVLHTALKAISS,KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid},A12D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 125 µM,Human,V13K Analogs,NA,Low hemolytic,CHHHHHHHHHHHHHHHGGGHHHHTCC,NA
8875,29280948,2017,KWKSFLKTFKSaKKTVLHTALKAISS,KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid},F9D/A12D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,<20 % Hemolysis at 250 µM,Human,V13K Analogs,NA,Low hemolytic,CHHHHHHHHHHHHHHHGGGTGGGTCC,NA
8876,29280948,2017,KWKSFLKTFKSaKKTVLHTALKAISS,KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid},A12D/V16D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,0 % Hemolysis at >500 µM,Human,V13K Analogs,NA,Non-hemolytic,CHHHHHHHHHHHIIIIIHHHHHHHCC,NA
8877,29280948,2017,KWKSFLKTfKSaKKTvLHTALKAISS,KWKSFLKTF{d}KSA{d}KKTV{d}LHTALKAISS{nt:Acet}{ct:Amid},F9D/A12D/V16D,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acids,26,Antimicrobial,0 % Hemolysis at >500 µM,Human,V13K Analogs,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHHHHHHHHTC,NA
9002,29310083,2018,kwLkkwLkwLkk,K{d}W{d}LK{d}K{d}W{d}LK{d}W{d}LK{d}K{d}{ct:Amid},DA-12,Amidation,Free,Linear,Mix,None,12,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,Non-hemolytic,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,NA
9003,29310083,2018,kwLkkwLkwLkk,K{d}W{d}{nnr:L}K{d}K{d}W{d}{nnr:L}K{d}W{d}{nnr:L}K{d}K{d}{ct:Amid},UNA-12,Amidation,Free,Linear,Mix,L = β-amino acid,12,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,Non-hemolytic,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,NA
9018,29407961,2018,dabDabDabLdabDabDabLdabDabDabLfDabDabLdabDabDabLfDabDabL,{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R6 = 4-methyl-hexanoyl}{ct:Amid},Lipopeptide-13,Amidation,R6 = 4-methyl-hexanoyl,Linear,Mix,"Dab = 2,4-diaminobutanoic acid, dab = D-2,4-diaminobutanoic acid, f = D-phenylalanine",24,"Antifungal, Antibiofilm",21 % Hemolysis at 1 mM,Mouse,Linear Battacin Analogue,NA,NA,NA,NA
9127,29501941,2018,VGAlAvVvWlWlWlW,VGAL{d}AV{d}VV{d}WL{d}WL{d}WL{d}W{nt:Formyl}{ct:NHCH2CH2OH},24(Gramicidin A),NHCH2CH2OH,Formyl,Linear,Mix,N-Terminal = Formyl,15,Antibacterial,50 % Hemolysis at 5 µM,Human,Gramicidin A Amp,β 6.3-Helical,NA,CGGGHHHHHHHHHHHCC,NA
9205,29738954,2018,FGrKKRrQrRr-βA,FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid},γTatM4,Amidation,Acetylation,Linear,Mix,"r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine",11,Antibacterial and Anti-TB,10 % Hemolysis at 1 µM,Human,Tat Peptide Analogues,NA,NA,NA,NA
9207,29738954,2018,FGrKKRrQrRr-βA,FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid},γTatM4,Amidation,Acetylation,Linear,Mix,"r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine",11,Antibacterial and Anti-TB,12 % Hemolysis at 40 µM,Human,Tat Peptide Analogues,NA,NA,NA,NA
9256,29621496,2018,NapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",6,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9257,29621496,2018,NapNdmbNapNdmbNapNdmb,{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{cyc:N-C},C2,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndmb = N-(3,5-dimethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 125 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9258,29621496,2018,NapNsneNapNsneNapNsne,{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{cyc:N-C},C3,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nsne = (S)-N-(1-naphthylethyl)glycine",6,Antibacterial,10 % Hemolysis,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9259,29621496,2018,NapNdpNapNdpNapNdp,{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{cyc:N-C},C4,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndp = N-(2,2-diphenylethyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9260,29621496,2018,NapNbtfmbNapNbtfmbNapNbtfmb,{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{cyc:N-C},C5,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nbtfmb = N-(3,5-bis-trifluoromethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9261,29621496,2018,NapNpmNapNpmNapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1dec,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",10,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9262,29621496,2018,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},CGS (gramicidin S),Free,Free,Cyclic,Mix,"O = L-Ornithine, f = D-phenylalanine",10,Antibacterial,10 % Hemolysis at >15.6 μg/ml,Human,Gram-Positive Bacterium Brevibacillus Brevis,NA,NA,NA,NA
9301,29799150,2018,AAGkwklfkklpkflhlakkf,AAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},AAG‐P18,Amidation,Free,Linear,Mix,None,18,Antibacterial,75 % Hemolysis at 250 µM,Human,Cecropin/Magainin Hybrid,NA,NA,CHHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9302,29799150,2018,EEEEAAAGkwklfkklpkflhlakkf,EEEEAAAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid},Pro‐P18,Amidation,Acetylation,Linear,Mix,None,26,ND,0 % Hemolysis at 10 µM,Human,Cecropin/Magainin Hybrid,NA,Non-hemolytic,CCCCGGGTGGGGCCSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9303,29799150,2018,AAGwglrrllkygkrs,AAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{ct:Amid},AAG‐WMR,Amidation,Free,Linear,Mix,None,13,Antibacterial,5 % Hemolysis at 10 µM,Human,Myxinidin Analogue From Hagfish,NA,NA,CCTTSSCCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
9304,29799150,2018,EEEEAAAGwglrrllkygkrs,EEEEAAAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{nt:Acet}{ct:Amid},Pro‐WMR,Amidation,Acetylation,Linear,Mix,None,21,ND,0 % Hemolysis at 10 µM,Human,Myxinidin Analogue From Hagfish,NA,Non-hemolytic,CCCCSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
9398,29750913,2018,Cyclo(1‑4)‑cILC-KKLFKKILKYL,C{d}ILC-KKLFKKILKYL{cyc:1‑4},Cyclo (1‑4)‑cILC-BP100,Free,Free,Cyclic,Mix,disulfide bond between D-Cys1 and Cys4 at N-Terminal,11,Antimicrobial,50 % Hemolysis at 8.7 µM,Human,Synthesized Analog Of Bp100,membrane =Partly α-Helical and partly β-Turn,NA,NA,NA
9407,29900628,2018,RVRWRlf-2-Abz-aRWRVR,RVRWRlF{d}{nnr:2-Abz}A{d}RWRVR,Peptide 2,Free,Free,Linear,Mix,"2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine",13,"Antibacterial, Antifungal",<3 % Hemolysis at 200 µM,Mouse,Synthetic Amphipathic Antimicrobial Peptide,aqueous = β‐Hairpin,Low hemolytic,NA,NA
9408,29900628,2018,RIKWRlf-2-Abz-aRWKIR,RIKWRlF{d}{nnr:2-Abz}A{d}RWKIR,Peptide 3,Free,Free,Linear,Mix,"2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine",13,Antibacterial,<3 % Hemolysis at 600 µM,Mouse,Synthetic Amphipathic Antimicrobial Peptide,aqueous = β‐Hairpin,Non-hemolytic,NA,NA
9429,30105347,2018,ADLPFeF,ADLPFE{d}F,PapR7-dE,Free,Free,Linear,Mix,e = D-glutamic acid,7,NA,50 % Hemolysis at 1 µM,Human,Synthetic Peptide,NA,NA,CCTHHHHHHHHHHHHHHTTSSSCCSSCCCCSSSSSSCSSSSTTCCCSCSSSSSTTCSSCCTTSCC,NA
9433,29760411,2018,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K{cyc},Paenialvin-A,Free,Free,Bicyclic,Mix,None,23,"Antibacterial,Antitumor",3.61 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9434,29760411,2018,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K{cyc},Paenialvin-B,Free,Free,Bicyclic,Mix,None,23,Antibacterial,1.93 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9436,29760411,2018,L-A{d}-L-L-I-R{d}-L-L-V{d}-K-L-T-L-T-K-K,L-A{d}-L-L-I-R{d}-L-L-V{d}-K-L-T-L-T-K-K{cyc},Paenialvin-D,Free,Free,Linear,Mix,None,16,Antibacterial,0.64 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,CHHHHHHHCCSSSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9445,30192822,2018,KLLKFVTKVGKAIFKALIKAi,KLLKFVTKVGKAIFKALIKAI{d},Ocellatin4-analogue,Free,Free,Linear,Mix,None,21,Antimicrobial,88 % Hemolysis at 25 mM,Human,Leptodatylus Ocellatus Analogue Of Ocellatin 4,amphipathic α-Helix,NA,CCSSSSSIIIIIHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
9451,30192822,2018,KLLKFVTKVGKAIFKALIKAi,KLLKFVTKVGKAIFKALIKAI{d},Ocellatin4-analogue,Free,Free,Linear,Mix,None,21,Antimicrobial,100 % Hemolysis at 50 mM,Human,Leptodatylus Ocellatus Analogue Of Ocellatin 4,amphipathic α-Helix,NA,CCSSSSSIIIIIHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
9457,30192822,2018,KLLKFVTKVGKAIFKALIKAi,KLLKFVTKVGKAIFKALIKAI{d},Ocellatin4-analogue,Free,Free,Linear,Mix,None,21,Antimicrobial,100 % Hemolysis at 75 mM,Human,Leptodatylus Ocellatus Analogue Of Ocellatin 4,amphipathic α-Helix,NA,CCSCCCGGGGSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
9463,30192822,2018,KLLKFVTKVGKAIFKALIKAi,KLLKFVTKVGKAIFKALIKAI{d},Ocellatin4-analogue,Free,Free,Linear,Mix,None,21,Antimicrobial,100 % Hemolysis at 100 mM,Human,Leptodatylus Ocellatus Analogue Of Ocellatin 4,amphipathic α-Helix,NA,CCBTTBC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
9493,30112781,2018,KβcfKK,K{nnr:β}{nnr:cf}KK{cyc:N-C},5a,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9494,30112781,2018,KβcfGK,K{nnr:β}{nnr:cf}GK{cyc:N-C},5b,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9495,30112781,2018,KβcfAK,K{nnr:β}{nnr:cf}AK{cyc:N-C},5c,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9496,30112781,2018,KβcfFK,K{nnr:β}{nnr:cf}FK{cyc:N-C},5d,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at 88 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9497,30112781,2018,KβdicfKK,K{nnr:β}{nnr:dicf}KK{cyc:N-C},6a,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 216 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9498,30112781,2018,KβdicfGK,K{nnr:β}{nnr:dicf}GK{cyc:N-C},6b,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9499,30112781,2018,KβdicfAK,K{nnr:β}{nnr:dicf}AK{cyc:N-C},6c,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 67 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9500,30112781,2018,KβdicfFK,K{nnr:β}{nnr:dicf}FK{cyc:N-C},6d,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 84 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9582,30135470,2018,R-dabVdabFLdabVLS,{nnr:R}-{nnr:dab}V{nnr:dab}FL{nnr:dab}VLS{cyc:N-C},PGP-E,Free,Free,Cyclic,Mix,"Dab = Diaminobutyric acid, R = CH2CH2CH3(propyl group)",9,Antimicrobial,<50 % Hemolysis at 200 µM,Human,Bacteria Paenibacillus Elgii Bc34-6,NA,NA,NA,NA
9592,30325566,2018,ELlVDlL,ELL{d}VDL{d}L{cyc:N-C}{nt:Amid},surfactin,Free,Amidation,Cyclic,Mix,l = D-Leucine,7,Antimicrobial,high % Hemolysis at 100 µM,Human,Bacteria Bacillus Subtilis,NA,NA,NA,NA
9593,30361948,2018,K*WKNle*K,K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},KKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,3 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9594,30361948,2018,R*WKNle*K,R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},RKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,4.3 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9595,30361948,2018,K*WRNle*K,K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},KRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,2 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9596,30361948,2018,K*WKNle*R,K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},KKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,5.4 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9597,30361948,2018,R*WRNle*K,R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},RRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,<1 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9598,30361948,2018,R*WKNle*R,R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},RKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,17 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9599,30361948,2018,K*WRNle*R,K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},KRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,5.6 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9600,30361948,2018,R*WRNle*R,R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},RRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,3.2 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9601,30361948,2018,K*WKNle*K,K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},KKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.5 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9602,30361948,2018,R*WKNle*K,R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},RKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.5 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9603,30361948,2018,K*WRNle*K,K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},KRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9604,30361948,2018,K*WKNle*R,K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},KKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.4 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9605,30361948,2018,R*WRNle*K,R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},RRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9606,30361948,2018,R*WKNle*R,R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},RKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,8.2 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9607,30361948,2018,K*WRNle*R,K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},KRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.8 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9608,30361948,2018,R*WRNle*R,R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},RRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9725,34377965,2019,klLsllLtlsLakaaklLtllLalsL,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid},D84 (Lys1-6 Lys-1),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 54.3 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CGGGGGGHHHHTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)O
9726,34377965,2019,klDabsllDabtlsDabakaaklDabtllDabalsDab,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab}{nt:Acet}{ct:Amid},D86 (Lys1-6 Dab-1),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >742 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9727,34377965,2019,klDapsllDaptlsDapakaaklDaptllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid},D105 (Lys1-6 Dap-1),Amidation,Acetylation,Linear,Mix,"L-Dap = (2,3-diaminopropionic acid)",26,Antibacterial,50 % Hemolysis at >1148 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9728,34377965,2019,klLsllLtlsLakaaklLtllLalsS,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid},D101 (Lys1Ser26-5 Lys-1),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 103.9 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CHHHHHHHHHHHTTSCCTTTSCSSSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
9729,34377965,2019,klDabsllDabtlsDabakaaklDabtllDabalsS,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid},D102 (Lys1Ser26-5 Dab-1),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >708 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9730,34377965,2019,klLsllLtlsaakLLklatllLalsL,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid},D88 (Lys1-6 Lys-2),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 80.6 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CCGGGGGHHHHTTSCSHHHHSSCCSCSSSCSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)O
9731,34377965,2019,klDabsllDabtlsaakDabDabklatllDabalsDab,AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid},D89 (Lys1-6 Dab-2),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >1112 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9732,34377965,2019,klDapsllDaptlsaakDapDapklatllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dap}{nnr:Dap}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid},D106 (Lys1-6 Dap-2),Amidation,Acetylation,Linear,Mix,"L-Dap = (2,3-diaminopropionic acid)",26,Antibacterial,50 % Hemolysis at 340.2 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9733,34377965,2019,klLsllLtlsaakLLklatllLalsS,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid},D103 (Lys1Ser26-5 Lys-2),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 134.9 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CCCSHHHHTTCCCCSSSTHHHHHCCCCSSCHHHHTSSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
9734,34377965,2019,klDabsllDabtlsaakDabDabklatllDabalsS,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dab}{nnr:Dab}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid},D104 (Lys1Ser26-5 Dab-2),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >1490 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9777,30702120,2019,RRWvRRvRRWvRRvvRvvRRWvRR,RRWV{d}RRV{d}RRWV{d}RRV{d}V{d}RV{d}V{d}RRWV{d}RR,D8,Free,Free,Linear,Mix,None,24,Antibacterial,0 ± 1 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9840,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,58 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9841,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,88 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9842,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,60 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9843,30842436,2019,K-K-l-K-(2-Nal)ala-f-(2-Nal)ala,K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},17,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,40 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9844,30842436,2019,(2-Nal)ala-f-(2-Nal)ala-K-l-K-K,{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-K-L{d}-K-K,18,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9845,30842436,2019,(2-Nal)ala-f-(2-Nal)ala-l-K-K-K,{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-L{d}-K-K-K,19,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9846,30842436,2019,(1-Nal)ala-f-(1-Nal)ala-K-l-K-K,{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-K-L{d}-K-K,20,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9847,30842436,2019,(1-Nal)ala-f-(1-Nal)ala-l-K-K-K,{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-L{d}-K-K-K,21,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9851,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,53 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9852,30842436,2019,K-K-K-nle-(1-Nal)ala-f-(1-Nal)ala,K-K-K-{nnr:nle}-(1-Nal)ala-F{d}-(1-Nal)ala,26,Free,Free,Linear,Mix,"nle = D-Norleucine, (1-Nal)Ala = 1-Naphthylalanine",7,Antimicrobial,56 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9854,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-(2-Nal)ala-Y{d}-(2-Nal)ala,28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,64 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9863,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 28 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9864,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 8 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9865,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 18 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9866,30842436,2019,K-K-l-K-(2-Nal)ala-f-(2-Nal)ala,K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},17,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 8 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9870,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 38 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9872,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala},28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 6 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9877,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 128 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9878,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 40 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9879,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 118 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9882,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 138 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9883,30842436,2019,K-K-K-nle-(1-Nal)ala-f-(1-Nal)ala,K-K-K-{nnr:nle}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},26,Free,Free,Linear,Mix,"nle = D-Norleucine, (1-Nal)Ala = 1-Naphthylalanine",7,Antimicrobial,50 % Hemolysis at 63 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9885,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala},28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 50 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9910,30848594,2019,klDabsllDabtlsDabakaaklDabtllDabalsDab,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab},D86(Lys¹-6 Dab-1),Amidation,Acetylation,Linear,Mix,Dab = diaminobutyric acid,26,Antimicrobial,50 % Hemolysis at >2000 μg/ml,Human,Synthetic Peptide,α-Helix,Low hemolytic,NA,NA
9911,30848594,2019,klDapsllDaptlsDapakaaklDaptllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}aK{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap},D105(Lys¹-6 Dap-1),Amidation,Acetylation,Linear,Mix,Dap = diaminopropionic acid,26,Antimicrobial,50 % Hemolysis at >3000 μg/ml,Human,Synthetic Peptide,α-Helix,Low hemolytic,NA,NA
9913,30848594,2019,klDabsllDabtlsDabakaaklDabtllDabalss,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{d},D102(Lys Ser26-5 Dab-1),Amidation,Acetylation,Linear,Mix,Dab = diaminobutyric acid,26,Antimicrobial,50 % Hemolysis at >2000 μg/ml,Human,Synthetic Peptide,α-Helix,Low hemolytic,NA,NA
9915,30848594,2019,klDabsllDabtlsDabaaaaalDabtllDabalsDab,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab},D86(K13A/K16A) -(Lys¹-6 Dab-1),Amidation,Acetylation,Linear,Mix,Dab = diaminobutyric acid,26,Antimicrobial,50 % Hemolysis at 20 μg/ml,Human,Synthetic Peptide,α-Helix,NA,NA,NA
9916,30848594,2019,klDapsllDaptlsDapaaaaalDaptllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap},D105(K13A/K16A) -(Lys'-6 Dap-1),Amidation,Acetylation,Linear,Mix,Dap = diaminopropionic acid,26,Antimicrobial,50 % Hemolysis at 7.2 μg/ml,Human,Synthetic Peptide,α-Helix,NA,NA,NA
9917,30973929,2019,EVlADlV,EVL{d}ADL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP1,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,7,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",40 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CHHHHHHHHHHHHHHHTTHHHHHHC,NA
9918,30973929,2019,EVlDlV,EVL{d}DL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP2,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,6,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCHHHHHHHHTTTCC,NA
9919,30973929,2019,EVlDl,EVL{d}DL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP3,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",80 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCHHHHHHHHTTTCC,NA
9920,30973929,2019,EVll,EVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP4,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,4,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",5 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,Low hemolytic,CHHHHHHSSCC,NA
9921,30973929,2019,EVlDl,EVL{d}DL{d}{nt:Palmityl}{ct:Amid},SLP5,Amidation,Palmityl,Linear,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",25 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCTHHHHHHHTC,NA
9922,30973929,2019,KVlKl,KVL{d}KL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP6,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",90 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCTHHHHHHHTC,NA
9924,30973929,2019,EVllD,EVL{d}L{d}D{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP8,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCSSSSSSCCSSSSSSSCCCCCC,NA
9925,30973929,2019,EDVll,EDVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP9,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",50 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCCCCCCSSCCGGGTCCCGGGTTTTTCCCCCSSTTTTGGGCCTTCC,NA
9926,30973929,2019,EVlDl,EVlDl{cyc:N-C}{nt:Heptaalkyl-biphenyl-acid}{ct:Amid},SLP10,Amidation,Heptaalkyl-biphenyl-acid,Cyclic,Mix,Heptaalkyl-biphenyl-acid,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",55 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCSCCCCTTSTTCCSTTCCCSTTHHHHCCTTTCCCCSSTTTCCSSSSSSCCTHHHHHHHHHTTSSCC,NA
9929,30753486,2019,VNWKKILGkIIKVVK,VNWKKILGK{d}IIKVVK{ct:Amid},LL-III/43,Amidation,Free,Linear,Mix,None,15,"Antibiofilm, Antifungal",50 % Hemolysis at 400 µM,Human,Derived From Ll-Iii But With D-Leu,30% TFE = α-Helix,NA,CCHHHHHHHHHHHTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9932,30753486,2019,GKWMKLlKKILK,GKWMKLL{d}KKILK{ct:Amid},peptide VIII,Amidation,Free,Linear,Mix,None,12,"Antibiofilm, Antifungal",50 % Hemolysis at 400 µM,Human,Modified Hal-2,30% TFE = α-Helix,NA,CCSSCCSCTTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
10401,32641937,2019,cyclo(CGAGHVPC)-Yy(GABA)fYG,CGAGHVPC-YY{d}{nnr:GABA}F{d}YG{cyc:1-8},MccJ25-derived peptide,Free,Free,Cyclic,Mix,GABA = gamma amino butyric acid,14,Antibacterial,0.26 ± 0.01 % Hemolysis at 200 µM,Human,Bacteria Enterobacteriacea Mccj25- Derived Peptide,β-Sheet,Non-hemolytic,NA,NA
10599,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF-W,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",12.1 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10600,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17mF-W,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",7.1 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,Low hemolytic,NA,NA
10601,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17W2,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",8 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,Low hemolytic,NA,NA
10602,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF2,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",32.5 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10603,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17B-tF,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",30.2 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10604,31319057,2019,GX1KRlVQRlKD X2lRKLV,G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",61.5 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10605,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF-W,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10606,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17mF-W,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10607,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17W2,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10608,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF2,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10609,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17B-tF,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10610,31319057,2019,GX1KRlVQRlKD X2lRKLV,G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at 180 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10690,31775224,2019,IRpIRp,IRP{d}IRP{d},DIR1,Free,Free,Linear,Mix,p = D-Proline,6,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,50% TFE = β-Sheet,Low hemolytic,CCGGGTTTHHHHTTTCCC,NA
10691,31775224,2019,IRIRpIRIRp,IRIRP{d}IRIRP{d},DIR2,Free,Free,Linear,Mix,p = D-Proline,10,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,"aqueous = unordered, 50% TFE = β-Sheet",Low hemolytic,CCTTGGGTHHHHHHHTCC,NA
10692,31775224,2019,IRIRIRpIRIRIRp,IRIRIRP{d}IRIRIRP{d},DIR3,Free,Free,Linear,Mix,p = D-Proline,14,"Antibacterial, Anti-Inflammatory",≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,"aqueous = unordered, 50% TFE = β-Hairpin",Low hemolytic,CCTTHHHHHHHHHHHTCC,NA
10739,31827113,2019,G-dab-GswS-Dab-dab-IEI-aIle-S,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S,M1 (or M),Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,10 % Hemolysis at 128 μg/ml,Rabbit,"Tridecaptin M A Mud Bacterium, Paenibacillus Sp. M-152",NA,Low hemolytic,NA,NA
10740,31827113,2019,G-dab-GswS-Dab-dab-IEVvS,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEVV{d}S,M2,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,2 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10741,31827113,2019,G-dab-GsDFS-Dab-dab-IEIvS,G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEIV{d}S,M5,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,0 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10742,31827113,2019,G-dab-GswS-Dab-dab-IEIvS,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEIV{d}S,M6,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,>15 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,NA,NA,NA
10743,31827113,2019,G-dab-GswS-Dab-dab-VEI-aIle-S,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-VEI-{nnr:aIle}-S,M7,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,1 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10744,31827113,2019,G-dab-GsDFS-Dab-dab-IEI-aIle-S,G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S,M8,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,>9 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Low hemolytic,NA,NA
10745,31827113,2019,dab-FEI-aIle-S,{nnr:dab}-FEI-{nnr:aIle}-S,M11,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",6,Antibacterial,50 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,NA,NA,NA
10803,31676352,2019,GLLk(C4)RIkTLL,GLLK{d}{conj:C4}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C4",Amidation,Free,Linear,Mix,C4 = C4,10,"Antibacterial,",10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10804,31676352,2019,GLLk(C6)RIkTLL,GLLK{d}{conj:C6}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C6",Amidation,Free,Linear,Mix,C6 = C6,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10805,31676352,2019,GLLk(C8)RIkTLL,GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10806,31676352,2019,GLLk(C10)RIkTLL,GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10807,31676352,2019,GLLk(C12)RIkTLL,GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10808,31676352,2019,GLLk(C14)RIkTLL,GLLK{d}{conj:C14}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C14",Amidation,Free,Linear,Mix,C14 = C14,10,Antibacterial,10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10809,31676352,2019,GLLk(C16)RIkTLL,GLLK{d}{conj:C16}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C16",Amidation,Free,Linear,Mix,C16 = C16,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10810,31676352,2019,GLLkRIk(C4)TLL,GLLK{d}RIK{d}{conj:C4}TLL{ct:Amid},"Ano-D4,7-7C4",Amidation,Free,Linear,Mix,C4 = C4,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10811,31676352,2019,GLLkRIk(C6)TLL,GLLK{d}RIK{d}{conj:C6}TLL{ct:Amid},"Ano-D4,7-7C6",Amidation,Free,Linear,Mix,C6 = C6,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10812,31676352,2019,GLLkRIk(C8)TLL,GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid},"Ano-D4,7-7C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10813,31676352,2019,GLLkRIk(C10)TLL,GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid},"Ano-D4,7-7C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 128 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10814,31676352,2019,GLLkRIk(C12)TLL,GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid},"Ano-D4,7-7C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10815,31676352,2019,GLLkRIk(C14)TLL,GLLK{d}RIK{d}{conj:C14}TLL{ct:Amid},"Ano-D4,7-7C14",Amidation,Free,Linear,Mix,C14 = C14,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10816,31676352,2019,GLLkRIk(C16)TLL,GLLK{d}RIK{d}{conj:C16}TLL{ct:Amid},"Ano-D4,7-7C16",Amidation,Free,Linear,Mix,C16 = C16,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10877,33479615,2020,GHrKPAQP,GHR{d}KPAQP,P1,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >50 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCCSSSCC,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
10878,33479615,2020,errKPAQP,E{d}R{d}R{d}KPAQP,P2,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCSTTTTC,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
10879,33479615,2020,eeEKPAQP,E{d}E{d}EKPAQP,P4,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >50 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCCCCC,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
10880,33479615,2020,efrTMVHPK,E{d}F{d}R{d}TMVHPK,P5,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCCCSSCC,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10881,33479615,2020,edRKHAQA,E{d}D{d}RKHAQA,P8,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >40 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCCSCCC,C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)O
10882,33479615,2020,kEFHKTAQP,K{d}EFHKTAQP,P9,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >60 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCSCCSSCCCCTTTCCCCC,C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
10883,33479615,2020,frrRPLRA,F{d}R{d}R{d}RPLRA,P13,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCCCSCCCCCSSCCCCGGGC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
10884,33479615,2020,DdhKTAHQ,DD{d}H{d}KTAHQ,P14,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >40 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCSSCHHHHHHHHIIIIITC,C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)O
10885,33479615,2020,GwRKPAQP,GW{d}RKPAQP,P16,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CTTHHHHHHHHHHHHHHHHC,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
10886,33479615,2020,wKrLHHKPA,W{d}KR{d}LHHKPA,P18,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic,CCSCSSCCTTTSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O
11357,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11358,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11362,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,34.3 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11363,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,30.8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11364,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11365,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",33.3 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11366,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,43.5 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11375,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11378,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,23.4 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11381,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,10.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11382,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,Low hemolytic,NA,NA
11386,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,25.8 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11387,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,25.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11388,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,36.3 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11389,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",40.7 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11390,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,50.2 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11399,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,19.9 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11402,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,38.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11405,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11406,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11410,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11411,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11412,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11413,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",11.3 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11414,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,17.9 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11423,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11426,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11429,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11430,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11434,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11435,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11436,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11437,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",17.4 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11438,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11447,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,16 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11450,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,29.8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11511,32590058,2020,kFwSLLkKALRLwANVL,K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid},CPF-2,Amidation,Free,Linear,Mix,None,17,"Antibiofilm, Antibacterial",100 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11512,32590058,2020,kfwsllkkalrlwanvl,K{d}F{d}W{d}S{d}L{d}L{d}K{d}K{d}A{d}L{d}R{d}L{d}W{d}A{d}N{d}V{d}L{d}{ct:Amid},DCPF-2,Amidation,Free,Linear,Mix,None,17,Antibacterial,100 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical (reverse Helical),NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11513,32590058,2020,kFwSLLkKAlrLwKkVL,K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}KK{d}VL{ct:Amid},CPF-2-1,Amidation,Free,Linear,Mix,None,17,Antibacterial,0 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11514,32590058,2020,kFwSLLkKAlrLwAkVL,K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}AK{d}VL{ct:Amid},CPF-2-2,Amidation,Free,Linear,Mix,None,17,Antibacterial,0 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11516,32590058,2020,GFGSLLGKALRLwKkVL,GFGSLLGKALRLW{d}KK{d}VL{ct:Amid},CPF-14,Amidation,Free,Linear,Mix,None,17,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical,NA,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11517,32590058,2020,GFGSLLGKAlrLwKkVL,GFGSLLGKAL{d}R{d}LW{d}KK{d}VL{ct:Amid},CPF-15,Amidation,Free,Linear,Mix,None,17,Antibacterial,≥75 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,NA,CCCCCSSSTTCSSCSSTTSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11518,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0 % Hemolysis at 5 µM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic,CCCCCSSSTTCSSCSSTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
11519,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0 % Hemolysis at 10 µM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic,CCCCCSSSTTCSSCSSTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
11520,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0.8 % Hemolysis at 20 µM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic,CCCCCSSSTTCSSCSSTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
11521,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,1.3 % Hemolysis at 40 µM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
11526,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0 % Hemolysis at 5 µM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic,CCCCCCSSSCCSSSSCCCSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11527,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0 % Hemolysis at 10 µM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic,CCCCCCSSSCCSSSSCCCSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11528,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0.8 % Hemolysis at 20 µM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic,CCCCCCSSSCCSSSSCCCSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11529,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,1.3 % Hemolysis at 40 µM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11534,32673701,2020,rRrRrRRR- DDDDEEEDDFVYFNFNKEKEE,R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE,rR8-JR helix,Free,Free,Linear,Mix,None,29,NA,0 % Hemolysis at 5 µM,Human,Combination Of Rr8 And Jr Helix Sequences,Random coil and Helical,Non-hemolytic,CCHHHHHHHHHHHGGGTCC,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.N=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N
11535,32673701,2020,rRrRrRRR- DDDDEEEDDFVYFNFNKEKEE,R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE,rR8-JR helix,Free,Free,Linear,Mix,None,29,NA,0 % Hemolysis at 10 µM,Human,Combination Of Rr8 And Jr Helix Sequences,Random coil and Helical,Non-hemolytic,CGGGGGGHHHHHHHHCC,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.N=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N
11536,32673701,2020,rRrRrRRR- DDDDEEEDDFVYFNFNKEKEE,R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE,rR8-JR helix,Free,Free,Linear,Mix,None,29,NA,0.8 % Hemolysis at 20 µM,Human,Combination Of Rr8 And Jr Helix Sequences,Random coil and Helical,Non-hemolytic,CTHHHHHHHHHHHHHHHTTSCCCSSCCSCC,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.N=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N
11537,32673701,2020,rRrRrRRR- DDDDEEEDDFVYFNFNKEKEE,R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE,rR8-JR helix,Free,Free,Linear,Mix,None,29,NA,1.1 % Hemolysis at 40 µM,Human,Combination Of Rr8 And Jr Helix Sequences,Random coil and Helical,Non-hemolytic,CCHHHHHHHHHHHGGGTCC,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.N=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N
11539,32786271,2020,kFFkrLLkSVrrAVkkFrk,K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid},HC1-D1,Amidation,Free,Linear,Mix,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",28 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = Random coil",NA,CGGGGGGHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11541,32786271,2020,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,Hc-CATH,Free,Free,Linear,Mix,None,30,"Antimicrobial, Anti-inflammatory, Anti-biofilm",37 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,amphipathic α-Helical,NA,CCCHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11543,32786271,2020,kFFkrLLkSVrrAVkkFrk,K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid},HC1-D1,Amidation,Free,Linear,Mix,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",9 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = Random coil",NA,CCSSCCCTHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11545,32786271,2020,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,Hc-CATH,Free,Free,Linear,Mix,None,30,"Antimicrobial, Anti-inflammatory, Anti-biofilm",16 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,amphipathic α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11551,32967333,2020,AlWkkllkk-Cha,AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid},DMPC-10B,Amidation,Free,Linear,Mix,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",0 % Hemolysis at 128 µM,Horse,Modificaiton Of Dmpc-10A,TFE = α-Helix,Non-hemolytic,NA,NA
11644,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C16},C16-fXXL,Free,C16,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11645,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C14},C14-fXXL,Free,C14,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11646,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12},C12-fXXL,Free,C12,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine",4,Antibacterial,<5 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11647,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C16},C16-fXXL,Free,C16,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,<5 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,NA,NA,NA
11648,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C14},C14-fXXL,Free,C14,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,NA,NA,NA
11649,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12},C12-fXXL,Free,C12,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine",4,Antibacterial,0 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,Non-hemolytic,NA,NA
11748,33296183,2021,FLK(2-NaI)LKKLL,FLK{nnr:D-2-NaI}LKKLL{ct:Amid},Feleucin-K56,Amidation,Free,Linear,Mix,D-2-nal = D-2-nal,9,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,Low hemolytic,NA,NA
11750,33469079,2021,RkRwWvVkRkWwV,RK{d}RW{d}WV{d}VK{d}RK{d}WW{d}V{ct:Amid},AS01,Amidation,Free,Linear,Mix,None,13,Antimicrobial,7.24 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,NA,CCCHHHHTTCCCCCC,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)O
11751,33469079,2021,RkRwLwLkRkWlW,RK{d}RW{d}LW{d}LK{d}RK{d}WL{d}W{ct:Amid},AS02,Amidation,Free,Linear,Mix,None,13,Antimicrobial,0 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,Non-hemolytic,CCCCCCCCCCSCCCCCTTSSCCSCCSCCCCTTSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11752,33469079,2021,KkKwWvKkKwWvV,KK{d}KW{d}WV{d}KK{d}KW{d}WV{d}V{ct:Amid},AS03,Amidation,Free,Linear,Mix,None,13,Antimicrobial,0 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,Non-hemolytic,CCGGGHHHHTTTC,CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)O
11753,33469079,2021,WwKkKvWvKkKwW,WW{d}KK{d}KV{d}WV{d}KK{d}KW{d}W{ct:Amid},AS04,Amidation,Free,Linear,Mix,None,13,Antimicrobial,0.25 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,Non-hemolytic,CCGGGHHHHTTTC,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11754,33469079,2021,KkKvVvKkKvVwK,KK{d}KV{d}VV{d}KK{d}KV{d}VW{d}K{ct:Amid},AS06,Amidation,Free,Linear,Mix,None,13,Antimicrobial,0 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,Non-hemolytic,CCCCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11755,33469079,2021,WlWlWlWvKkAkAkK,WL{d}WL{d}WL{d}WV{d}KK{d}AK{d}AK{d}K{ct:Amid},AS08,Amidation,Free,Linear,Mix,None,15,Antimicrobial,1.46 % Hemolysis at 8 µM,Human,Synthetic Syndiotactic Polypeptides,Helical,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11948,34220763,2021,Wkklkkllkklkkl,WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid},pepdD2,Amidation,Acetylation,Linear,Mix,None,14,"Antibacterial, Antibiofilm",2.9 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11955,34205705,2021,KKLfKKILKYL,KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid},BP472,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,11,"Antifungal, Antibacterial",78 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11956,34205705,2021,KKLfKK(COC3H7)ILKYL,KKL{d}F{d}KK{conj:COC3H7}IL{d}KYL{d}{nt:Acet}{ct:Amid},BP473,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",84 ± 11 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11957,34205705,2021,KKLfKKIK(COC3H7)KYL,KKL{d}F{d}KKIK{conj:COC3H7}KYL{d}{nt:Acet}{ct:Amid},BP474,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11958,34205705,2021,KKLfKKILKK(COC3H7)L,KKL{d}F{d}KKIL{d}KK{conj:COC3H7}L{d}{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,α-Helical,Non-hemolytic,NA,NA
11959,34205705,2021,KKLfKKILKYK(COC11H23),KKL{d}F{d}KKIL{d}KYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP476,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",94 ± 10 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11960,34205705,2021,KKLk(COC5H11)KKILKYL,KKL{d}k{conj:COC5H11}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP484,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",10 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11961,34205705,2021,KKLfKKILKYL,KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid},BP485,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,11,"Antifungal, Antibacterial",24 ± 9 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11962,34205705,2021,KK(COC3H7)LfKKILKYL,KK{conj:COC3H7}L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP486,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",14 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11963,34205705,2021,KKLk(COC11H23)KKILKYL,KKL{d}k{conj:COC11H23}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP488,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",86 ± 14 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11964,34205705,2021,KKLfKKK(COC11H23)LKYL,KKL{d}F{d}KKK{conj:COC11H23}L{d}KYL{d}{nt:Acet}{ct:Amid},BP489,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11965,34205705,2021,KKLfKKIK(COC11H23)KYL,KKL{d}F{d}KKIK{conj:COC11H23}KYL{d}{nt:Acet}{ct:Amid},BP490,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11966,34205705,2021,KKLfKKK(COC5H11)LKYL,KKL{d}F{d}KKK{conj:COC5H11}L{d}KYL{d}{nt:Acet}{ct:Amid},BP494,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.2 ± 0.2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11967,34205705,2021,KKLfKKILKYK(COC5H11),KKL{d}F{d}KKIL{d}KYK{conj:COC5H11}{nt:Acet}{ct:Amid},BP495,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.6 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11968,34205705,2021,KKLfKKILKYK(COC3H7),KKL{d}F{d}KKIL{d}KYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP496,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",1 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11969,34205705,2021,KKLfKKILK(COC11H23)YL,KKL{d}F{d}KKIL{d}K{conj:COC11H23}YL{d}{nt:Acet}{ct:Amid},BP497,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11970,34205705,2021,KKLfK(COC3H7)KILKYL,KKL{d}F{d}K{conj:COC3H7}KIL{d}KYL{d}{nt:Acet}{ct:Amid},BP498,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",21 ± 3 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11971,34205705,2021,KKLfKKILK(COC3H7)YL,KKL{d}F{d}KKIL{d}K{conj:COC3H7}YL{d}{nt:Acet}{ct:Amid},BP499,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",11 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11972,34205705,2021,KKK(COC11H23)fKKILKYL,KKK{conj:COC11H23}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP500,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",71 ± 8 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
12135,34342438,2021,OpFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"O = L-Ornithine, p = D-Proline",30,Antibacterial,1.1 ± 0.9 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12136,34342438,2021,opFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[D-Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"o = D-Ornithine, p = D-Proline",30,Antibacterial,3.6 ± 0.7 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12236,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12237,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.8 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12244,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.1 ± 1.0 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12245,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",8.3 ± 0.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12246,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",62.2 ± 4.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12247,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",92.1 ± 5.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12248,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",7.2 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12267,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.8 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12268,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.7 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12275,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.8 ± 0.8 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12276,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",20.4 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12277,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",73.6 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12278,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",96.6 ± 3.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12279,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",12.5 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12298,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",1.3 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12299,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",1.5 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12306,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",10.0 ± 5.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12307,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",46.8 ± 3.3 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12308,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",100.0 ± 2.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12309,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",99.1 ± 8.0 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12310,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",39.0 ± 1.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12361,34959645,2021,GXKRlVQRlKDXLRNLV,G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,X = biphenylalanines,17,"Antibacterial, Antibiofilm",50 % Hemolysis at ~200 µM,Human,Ll-37 Derived Peptide,"PBS = distorted, 60mMSDS = Helical",NA,NA,NA
12372,34977576,2021,BkKlLkClKcLl,{nnr:B}K{d}KL{d}LK{d}CL{d}KC{d}LL{d}{cyc:7-10},bp67,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at >2000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12373,34977576,2021,BKKLLKcLKcLL,{nnr:B}KKLLKC{d}LKC{d}LL{cyc:7-10},bp68,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12374,34977576,2021,BkkLLkCLkCLL,{nnr:B}K{d}K{d}LLK{d}CLK{d}CLL{cyc:7-10},bp69,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12377,34977576,2021,kkLLkLLkLLL,K{d}K{d}LLK{d}LLK{d}LLL,ln69,Free,Free,Linear,Mix,None,12,Antibacterial,MHC at 1000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,CCCCSSCCCCCSCCCCCSSSTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
12378,34977576,2021,Tol-kkLLk-Cm-Lk-Cm-LL,{nnr:Tol}-K{d}K{d}LLK{d}-{nnr:Cm}-LK{d}-{nnr:Cm}-LL,ln69b,Free,Free,Linear,Mix,"Tol = toluoyl group, Cm = S-methyl cysteine",12,Antibacterial,MHC at 1000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12440,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.61 ± 0.47 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12441,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.83 ± 1.08 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12442,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,3.49 ± 0.76 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12443,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",0.11 ± 0.19 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12444,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.26 ± 0.54 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12445,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,2.33 ± 1.51 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12446,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.53 ± 1.12 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12447,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.91 ± 0.38 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12448,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.63 ± 0.24 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12449,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.31 ± 0.37 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12450,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.65 ± 0.60 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12454,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,5.49 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12455,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,5.99 ± 0.79 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12456,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.04 ± 0.20 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12457,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",3.69 ± 0.01 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12458,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,2.49 ± 0.72 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12459,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,3.25 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12460,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.11 ± 0.19 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12461,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.38 ± 0.58 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12462,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.53 ± 0.09 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12463,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.28 ± 0.19 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12464,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.42 ± 0.15 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12468,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,39.81 ± 0.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12469,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,39.16 ± 1.75 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12470,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,38.13 ± 3.12 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12471,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",18.75 ± 0.42 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12472,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,29.72 ± 0.94 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12473,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,32.57 ± 1.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12474,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,16.17 ± 3.36 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12475,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,26.19 ± 0.10 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12476,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,18.14 ± 0.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12477,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,19.20 ± 2.16 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12478,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,17.36 ± 1.92 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12482,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,52.88 ± 3.06 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12483,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,62.12 ± 6.27 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12484,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,55.73 ± 5.27 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12485,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",48.55 ± 2.53 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12486,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,51.41 ± 4.64 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12487,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,55.81 ± 2.87 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12488,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.65 ± 5.13 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12489,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,50.11 ± 3.17 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12490,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.18 ± 2.41 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12491,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.08 ± 4.70 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12492,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,46.97 ± 6.45 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12549,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12553,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12557,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CHHHHGGGTC,NA
12561,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CTHHHHTTTC,NA
12634,36442155,2022,rrrrWWWW,R{d}R{d}R{d}R{d}WWWW{cyc:N-C},4a,Free,Free,Cyclic,Mix,r = D-Arginine,8,Antibacterial,50 % Hemolysis at 110 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSCC,NA
12689,36555393,2022,GIGAVLKVLTTGLPALISWIKRKRQQGGGGSklaklakklaklak,GIGAVLKVLTTGLPALISWIKRKRQQGGGGSK{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}A{d}K{d}L{d}A{d}K{d}{nt:(FITC)-Ahx = Fluorescein isothiocyanate},melittin-dKLA,Free,(FITC)-Ahx = Fluorescein isothiocyanate,Linear,Mix,nter = (FITC)-Ahx,45,NA,100 % Hemolysis at 40 µM,Mouse,Modified Melittin,NA,NA,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12690,36555393,2022,VLTTGLPALISWIKRKRQQGGGGSklaklakklaklak,VLTTGLPALISWIKRKRQQGGGGSK{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}A{d}K{d}L{d}A{d}K{d}{nt:(FITC)-Ahx = Fluorescein isothiocyanate},melittin-dKLA 8-26,Free,(FITC)-Ahx = Fluorescein isothiocyanate,Linear,Mix,nter = (FITC)-Ahx,38,Anticancer,<5 % Hemolysis at 40 µM,Mouse,Modified Melittin,NA,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12790,37251186,2023,KKKKKGIGfLAfGAFVILKKKK,KKKKKGIGF{d}LAF{d}GAFVILKKKK{ct:Amid},MSI-Seg-F2F,Amidation,Free,Linear,Mix,None,22,Antibacterial,8.1 ± 3.2 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC and LPS = β-Sheet,NA,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12797,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,4.8 % Hemolysis at 200 µM (1 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCCSTHHHHHHHHTTCTTSSCGGGCCSCCCCCC,NA
12798,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,8.3 % Hemolysis at 200 µM (2 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCHHHHHHHHTTTC,NA
12799,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,16.4 % Hemolysis at 200 µM (4 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCHHHHHHHHTTCC,NA
12882,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C2},PE-2C-C2-DH,Free,C2,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12883,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C3},PE-2C-C3-DH,Free,C3,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12884,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C4},PE-2C-C4-DH,Free,C4,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12885,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C5},PE-2C-C5-DH,Free,C5,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12886,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C6},PE-2C-C6-DH,Free,C6,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12887,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C7},PE-2C-C7-DH,Free,C7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12888,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C8},PE-2C-C8-DH,Free,C8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12889,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC7},PE-2C-6-MC7-DH,Free,6-MC7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12890,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC8},PE-2C-6-MC8-DH,Free,6-MC8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12891,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:LB-8},PE-2C-LB-8-DH),Free,LB-8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at 1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12905,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼50 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCGGGTTTSCC,NA
12907,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼25 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHHHC,NA
12908,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3,DLeu9] TL (TL1)",Amidation,Free,Linear,Mix,l=D-Leu,13,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12909,35216177,2022,FVPWFSKFlPRIL,FVPWFSKFL{d}PRIL{ct:Amid},"[Pro3,DLeu9,Pro10] TL (TL2)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCTHHHHTTTC,NA
12910,35216177,2022,FVPWFSKFlpRIL,FVPWFSKFL{d}P{d}RIL{ct:Amid},"[Pro3,DLeu9,DPro10] TL (TL3)",Amidation,Free,Linear,Mix,"l=D-Leu, p = D-Pro",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12911,35216177,2022,FVPWFSKFlORIL,FVPWFSKFL{d}{nnr:O}RIL{ct:Amid},"[Pro3,DLeu9,Hyp10] TL (TL4)",Amidation,Free,Linear,Mix,"l=D-Leu, O = Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12912,35216177,2022,FVPWFSKFloRIL,FVPWFSKFL{d}{nnr:o}RIL{ct:Amid},"[Pro3,DLeu9,DHyp10] TL (TL5)",Amidation,Free,Linear,Mix,"l=D-Leu, o = D-Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12913,35216177,2022,FVPWFSKFlNRIL,FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid},"[Pro3,DLeu9,Nle10] TL (TL6)",Amidation,Free,Linear,Mix,"l=D-Leu, N = Nle",14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHTTTC,NA
12914,35216177,2022,FVPWFSKFlnRIL,FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid},"[Pro3,DLeu9,DNle10] TL (TL7)",Amidation,Free,Linear,Mix,"l=D-Leu, n = D-Nle",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12915,35216177,2022,FVPWFSKFlKRIL,FVPWFSKFL{d}KRIL{ct:Amid},"[Pro3,DLeu9,Lys10] TL (TL8)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12916,35216177,2022,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},"[Pro3,DLeu9,DLys10] TL (TL9)",Amidation,Free,Linear,Mix,"l=D-Leu, k = D-Lys",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCSGGGTGGGC,NA
12917,35216177,2022,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},"[Pro3,DLeu9,Trp10] TL (TL10)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCGGGTTCSCC,NA
12918,35216177,2022,FVPWFSKFlwRIL,FVPWFSKFL{d}W{d}RIL{ct:Amid},"[Pro3,DLeu9,DTrp10] TL (TL11)",Amidation,Free,Linear,Mix,"l=D-Leu, w = D-Trp",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12919,35216177,2022,FVPWFSKFlAicRIL,FVPWFSKFl{nnr:Aic}RIL{ct:Amid},"[Pro3,DLeu9,Aic10] TL (TL12)",Amidation,Free,Linear,Mix,Aic = 2-aminoindane-2-carboxylic acid,14,"Antibacterial, Anti-biofilm",100 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
13002,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13003,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13004,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13005,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1±0.62 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13006,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13007,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13008,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7±0.55 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13009,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13010,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1.8±0.9 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13011,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",52.74 ± 5.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13012,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2.88 ± 1.24 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13013,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2 ± 0.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13014,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",55.07 ± 5.23 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13015,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",18.18 ± 7.65 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13016,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7.49 ± 1.20 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13017,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.93 ± 6.02 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13018,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",42.93 ± 4.75 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13019,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",44.69 ± 3.73 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13020,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",61.64 ± 13.83 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13021,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",47.60 ± 7.88 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHHHTTCC,NA
13022,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",57.01 ± 8.50 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTTHHHHHHHTTTC,NA
13023,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",64.71 ± 11.34 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,NA,NA,NA
13024,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",51.15 ± 10.41 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13025,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.97 ± 5.51 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13113,35740884,2022,FLPLIIGALSSLLPKiF,FLPLIIGALSSLLPKI{d}F{ct:Amid},Temporin-PKE-i,Amidation,Free,Linear,Mix,i = D-Isoleucine,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 68.37 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,NA,NA
13114,35740884,2022,FLPLiiGALSSLLPKiF,FLPLI{d}I{d}GALSSLLPKI{d}F{ct:Amid},Temporin-PKE-3i,Amidation,Free,Linear,Mix,i = D-Isoleucine,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 64 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,NA,NA
13116,35740895,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a] SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antimicrobial, Antiproliferative",50 % Hemolysis at 43.66 ± 1.01 µM,Human,Analog Of Temporin-Sha,α-Helix,NA,CHHHHHHHHTTTC,NA
13117,35740895,2022,FLSGIVGMLaKLFK-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid},[G10a]2 SHa,Amidation,Free,Linear,Mix,"a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39",27,"Antimicrobial, Antiproliferative",50 % Hemolysis at 11.55 ± 0.38 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,NA,NA
13118,35740895,2022,FLSGIVGMLaKLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid},[G10a]3 SHa,Amidation,Free,Branched,Mix,"a = D-alanine, Linked b/w Lys27 and Phe27",41,"Antimicrobial, Antiproliferative",50 % Hemolysis at 10.46 ± 0.36 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,NA,NA
13119,35740895,2022,FLSGIVGMLaKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid},Jeff-[G10a2 SHa conjugate,Amidation,Free,Linear,Mix,Jeffamine linker b/w Phe13 and Phe26,26,"Antimicrobial, Antiproliferative",50 % Hemolysis at 1926 ± 242 µM,Human,Dendrimeric Analog Of Temporin-Sha,Triple Helical,Non-hemolytic,NA,NA
13121,35740895,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a] SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antimicrobial, Antiproliferative",102.03 ± 6.18 % Hemolysis at 100 µM,Human,Analog Of Temporin-Sha,α-Helix,NA,NA,NA
13122,35740895,2022,FLSGIVGMLaKLFK-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid},[G10a]2 SHa,Amidation,Free,Linear,Mix,"a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39",27,"Antimicrobial, Antiproliferative",100 % Hemolysis at 100 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,NA
13123,35740895,2022,FLSGIVGMLaKLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid},[G10a]3 SHa,Amidation,Free,Branched,Mix,"a = D-alanine, Linked b/w Lys27 and Phe27",41,"Antimicrobial, Antiproliferative",100 % Hemolysis at 100 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,NA
13124,35740895,2022,FLSGIVGMLaKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid},Jeff-[G10a2 SHa conjugate,Amidation,Free,Linear,Mix,"a = D-alanine, Jeffamine linker b/w Phe13 and Phe26",26,"Antimicrobial, Antiproliferative",24.01 ± 5.06 % Hemolysis at 100 µM,Human,Dendrimeric Analog Of Temporin-Sha,Triple Helical,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,NA
13141,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid}{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,3 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13143,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{nnr:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,NA
13151,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,7 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13152,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 1.0 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13159,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13160,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 6.1 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13167,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,5 ± 0.5 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13168,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,5 ± 1.9 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13171,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,4 ± 0.4 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13172,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,9 ± 1.0 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13181,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,7 ± 2 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13183,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{nnr:COC3H7}L{ct:Acet}{ct:Acet},BP475,Acetylation,Free,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,11 ± 5 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,NA
13191,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,28 ± 2.3 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13192,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,0 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13199,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.7 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13200,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.6 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13207,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,8 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13208,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,9 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13211,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,11 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13212,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,18 ± 1.4 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13221,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,6 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13223,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,NA
13231,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,43 ± 2.7 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13232,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13239,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.2 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13240,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 7.1 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13247,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,10 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13248,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,16 ± 1.9 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCCCC,NA
13251,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,18 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13252,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,26 ± 2.8 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13261,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,7 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13263,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,NA
13271,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,46 ± 3.6 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13272,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13279,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 10.6 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13280,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 7.0 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13287,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,17 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13288,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,29 ± 0.9 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13291,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,24 ± 0.5 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13292,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,39 ± 2.0 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13350,35847280,2022,QrwGlSlAPYkNFrrlS,QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S,ASU2056,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<1 % Hemolysis at 32 µM,Human,Synthetic,NA,Low hemolytic,CCCCCCSCCCCCCCTTC,NA
13351,35847280,2022,QrwGlSlAPYkNFrrlS,QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S,ASU2056,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<1 % Hemolysis at 64 µM,Human,Synthetic,NA,Low hemolytic,CHHHHHHHHHHHTSCGGGGGTTTHHHHHGGGSCCSCC,NA
13352,35847280,2022,QrwGlSlAPYkNFrrlS,QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S,ASU2056,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<1 % Hemolysis at 128 µM,Human,Synthetic,NA,Low hemolytic,CHHHHHHHHHHHTSCGGGGGTTTHHHHHGGGSCCSCC,NA
13353,35847280,2022,VGrwSArYNFrwrkSGl,VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d},ASU2060,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<0.1 % Hemolysis at 8 µM,Human,Synthetic,NA,Low hemolytic,CHHHHHHHHHHHHCHHHHHHHHHHHHHHHHTTCSSCC,NA
13354,35847280,2022,VGrwSArYNFrwrkSGl,VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d},ASU2060,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<0.1 % Hemolysis at 16 µM,Human,Synthetic,NA,Low hemolytic,CTHHHHHHHHTTTSHHHHTTTCCSCC,NA
13355,35847280,2022,VGrwSArYNFrwrkSGl,VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d},ASU2060,Free,Free,Linear,Mix,Lower-case letters signify D-amino acids,17,Antimicrobial,<0.1 % Hemolysis at 32 µM,Human,Synthetic,NA,Low hemolytic,CCTHHHHHHHHHHSTTTSHHHHTSCC,NA
13390,35700987,2022,(DG)-K-W-W-Orn-N-Nva-Aib-R-W-W,{nnr:DG}-K-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W,DG-K-oLBF127,Free,Free,Linear,Mix,"Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid",10,Antifungal,Hemolysis at 25 µM,mouse,Synthetic; K-Olbf127 Analogs,α-Helix,NA,NA,NA
13391,35700987,2022,k-w-w-orn-n-nva-{nnr:Aib}-r-w-w,K{d}-W{d}-W{d}-{nnr:orn}-N{d}-{nnr:nva}-{nnr:Aib}-R{d}-W{d}-W{d},ki-oLBF127,Free,Free,Linear,Mix,"Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids",10,Antifungal,Hemolysis at 20 µM,mouse,Synthetic; K-Olbf127 Analogs,α-Helix,NA,NA,NA
13392,35700987,2022,k-w-w-r-{nnr:Aib}-nva-n-orn-w-w,K{d}-W{d}-W{d}-R{d}-{nnr:Aib}-{nnr:nva}-N{d}-{nnr:orn}-W{d}-W{d},kri-oLBF127,Free,Free,Linear,Mix,"Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids",10,Antifungal,Hemolysis at >200 µM,mouse,Synthetic; K-Olbf127 Analogs,α-Helix,NA,NA,NA
13393,35700987,2022,K-w-w-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-w-w,K-W{d}-W{d}-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W{d}-W{d},kw-oLBF127,Free,Free,Linear,Mix,"Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids",10,Antifungal,Hemolysis at 80 µM,mouse,Synthetic; K-Olbf127 Analogs,α-Helix,NA,NA,NA
13758,35972429,2022,RRRLCFVRpKFVVCVRRp,RRRLCFVRP{d}KFVVCVRRP{d},PLP-3,Free,Free,Linear,Mix,None,18,Antimicrobial,50 % Hemolysis at 48.5 mg/L,Human,Protegrin-1 (Pg-1) Analog,β-Hairpin,Non-hemolytic,CCCCCCCCSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
13775,25561178,2015,xISqiIStAXI,{nnr:x}ISQ{d}I{d}IST{d}A{nnr:X}I,Teixobactin,Free,Free,Linear,Mix,"x = NmPhe(N-methylated phenylalanine), X = End (Enduracididine)",11,"Anticancer, Antibacterial",No Hemolysis,Human,Eleftheria Terrae,NA,Non-hemolytic,NA,NA
13781,25485686,2015,TrSGxLrEqwIT,TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT,Lysocin E,Free,Free,Linear,Mix,x = D-N-Methylphenylalanine,12,"Antibacterial, Antifungal",<1 % Hemolysis at 100 μg/ml,Sheep,Lysobacter,NA,Non-hemolytic,NA,NA
13782,25485686,2015,TrSGxLrEqwIT,TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT,Lysocin E,Free,Free,Linear,Mix,x = D-N-Methylphenylalanine,12,"Antibacterial, Antifungal",<1 % Hemolysis at 100 μg/ml,Horse,Lysobacter,NA,Non-hemolytic,NA,NA
13811,8223491,1993,IlGPVLGLVGSALGGLLKKI,I{nnr:l}GPVLGLVGSALGGLLKKI,Bombinin H4,Free,Free,Linear,Mix,l = D-aILe(D-alloisoleucine),20,"Antibacterial, hemolytic, Antifungal, candidacidal, Antiparasitic",Hemolysis at 14.6 µM,Human,"Yellow-Bellied Toad, Bombina Variegata L, Europe",Helix,NA,NA,NA
13833,9022710,1993,IlGPVLGMVGSALGGLLKKI,I{nnr:l}GPVLGMVGSALGGLLKKI,Bombinin H3,Free,Free,Linear,Mix,l = D-alloisoleucine,20,"Antibacterial, Hemolytic",Hemolytic at 15.7 µM,Human,"Toad, Bombina Variegata, Europe",NA,NA,NA,NA